Publications

1. Cathcart-Rake EJ, Tevaarwerk A, Jatoi A, Carroll EF, Scout N, Chedid VG, Gonzalez CA, Fee-Schroeder K, Kling JM, Shufelt CL, Ridgeway JL, Davidge-Pitts C. Building a Cancer Care Clinic for Transgender and Gender Diverse Individuals. Mayo Clin Proc Innov Qual Outcomes. 2024 Oct; 8 (5):443-450 Epub 2024 Aug 22
   View PubMed
2. Cathcart-Rake EJ, Jatoi A, Dressler EV, Kittel C, Weaver KE, Nightingale C, Neuman H, Loh KP, Kamen C, Landscape Committee. Sexual Orientation and Gender Identity Data Collection in Cancer Care: A Nationwide Landscape Assessment Update. JCO Oncol Pract. 2024 Sep; 20 (9):1272-1279 Epub 2024 May 20
   View PubMed
3. Kailasam A, Jatoi A, Reynolds E, Cliby W, Langstraat C. Understanding the patient experience in nonsurgical management of endometrial cancer and complex atypical hyperplasia due to obesity: A qualitative analysis. Gynecol Oncol Rep. 2024 Aug; 54:101425 Epub 2024 May 27
   View PubMed
4. Kamaraju S, McKoy J, Williams GR, Gilmore N, Minami C, Bylow K, Rajalingam H, Cortina CS, Beckert A, Stolley M, Bullock D, Kurzrock R, Jatoi A. An Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer. Curr Oncol Rep. 2024 Aug; 26 (8):855-864 Epub 2024 May 27
   View PubMed
5. O'Sullivan CC, Vierkant RA, Larson NL, Smith ML, Chauhan C, Couch FJ, Olson JE, D'Andre S, Jatoi A, Ruddy KJ. Advocate-BREAST80+: A Comprehensive Patient and Advocate-Led Study to Enhance Breast Cancer Care Delivery and Patient-Centered Research in Women Aged =80 Years. Cancers (Basel). 2024 Jul 09; 16(14).
   View PubMed
6. Sedrak MS, Lee MK, Ji J, Satele DV, Freedman RA, Poorvu PD, O'Connor T, Williams GR, Hopkins JO, Muss HB, Cohen HJ, Partridge AH, Carey LA, Chow SL, Subbiah N, Le-Rademacher J, Jatoi A. Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601). J Geriatr Oncol. 2024 Jul; 15 (6):101813 Epub 2024 June 08
   View PubMed
7. Cathcart-Rake E, Jatoi A. Educational Initiatives to Improve the Cancer-Related Disparities Facing Transgender and Gender Diverse (TGD) Individuals. J Cancer Educ. 2024 Jun 23 Epub 2024 June 23
   View PubMed
8. Fee-Schroeder K, Young C, Chedid V, Jatoi A, Cathcart-Rake E. How to Engage Older LGBTQIA+ Patients: Lessons Learned From Mayo Clinic Connect, a 100,000+-Participant Social Media Platform. Am J Hosp Palliat Care. 2024 Jun 19; 10499091241263333 Epub 2024 June 19
   View PubMed
9. Kalogera E, Nevala WK, Finnes HD, Suman VJ, Schimke JM, Strand CA, Kottschade LA, Kudgus RA, Buhrow SA, Becher LR, Geng L, Glaser GE, Grudem ME, Jatoi A, Klampe CM, Kumar A, Langstraat CL, McWilliams RR, Wahner Hendrickson AE, Weroha SJ, Yan Y, Reid JM, Markovic SN, Block MS. A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clin Cancer Res. 2024 Jun 14; 30 (12):2623-2635
   View PubMed
10. Haemmerle RJ, Jatoi A. Vitamin and Mineral Supplementation, Weight Gain, and Poor Appetite in Patients With Cancer: Many Questions and Fewer Answers. JCO Oncol Pract. 2024 Mar; 20 (3):323-327 Epub 2023 Dec 21
    View PubMed
11. Hillman SL, Jatoi A, Mandrekar SJ. Unveiling an Overlooked Link-Promising Drug Efficacy in Lowering Withdrawal Rates in Cancer Trials-Reply. JAMA Oncol 2024 Mar 1; 10 (3):411
    View PubMed
12. Cathcart-Rake EJ, Ruddy KJ, Tevaarwerk AJ, Jatoi A. Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals. Maturitas. 2024 Mar; 181:107913 Epub 2024 Jan 17
    View PubMed
13. Ehret CJ, Le-Rademacher JG, Martin N, Jatoi A. Dexamethasone and hiccups: a 2000-patient, telephone-based study. BMJ Support Palliat Care. 2024 Jan 8; 13 (e3):e790-e793 Epub 2024 Jan 08
    View PubMed
14. Ehret CJ, Martin N, Jatoi A. Baclofen for hiccups: a large mixed methods multisite study. BMJ Support Palliat Care. 2024 Jan 8; 13 (e3):e1405-e1408 Epub 2024 Jan 08
    View PubMed
15. Washburn L, Mahipal A, Jatoi A, Kottschade L, Tran N. Postpartum related intrahepatic cholangiocarcinoma with FGFR2 fusion and severe hyperbilirubinemia with response to FGFR inhibitor pemigatinib: case report and review. J Gastrointest Oncol. 2023 Dec 31; 14 (6):2627-2636 Epub 2023 Dec 12
    View PubMed
16. Rosser BRS, Weideman BCD, Rider GN, Jatoi A, Ecklund AM, Wheldon CW, Talley KMC, Kulasingam S, Smith MK, Jacobs DR, Mitteldorf D, West W, Alley R, Ross MW. Sexual and Gender Minority Invisibility in Cancer Studies: A Call for Effective Recruitment Methods to Address Cancer Disparities. J Clin Oncol. 2023 Nov 20; 41 (33):5093-5098 Epub 2023 Sept 19
    View PubMed
17. Philpot LM, Ramar P, Jatoi A, Rosedahl J, Canning R, Ebbert JO. Cannabis in Cancer Survivors Who Report High Impact Chronic Pain: Findings from a 1500+ Patient Survey. Am J Hosp Palliat Care. 2023 Nov; 40 (11):1196-1204 Epub 2022 Dec 05
    View PubMed
18. Laird BJA, Jatoi A. Cancer cachexia: learn from yesterday, live for today and hope for tomorrow. Curr Opin Support Palliat Care 2023 Sep 1; 17 (3):161 Epub 2023 July 27
    View PubMed
19. Haemmerle RJ, Jatoi A. Loss of appetite in patients with cancer: an update on characterization, mechanisms, and palliative therapeutics. Curr Opin Support Palliat Care. 2023 Sep 1; 17 (3):168-171 Epub 2023 July 27
    View PubMed
20. Smith RS, Foster NR, Jatoi A, Thome SD, Miller RC. Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: a Report from Three Prospective Alliance Clinical Trials. J Gastrointest Cancer. 2023 Sep; 54 (3):846-854 Epub 2022 Oct 17
    View PubMed
21. Tran NH, Almodallal Y, Batheja M, Martin NA, Le-Rademacher J, Ridgeway JL, Sia IG, Jatoi A. Social determinants of health: a need for better data capture in Asian American patients with hepatocellular cancer. Support Care Cancer. 2023 Aug 30; 31 (9):543
    View PubMed
22. Dasgupta A, Gibbard DF, Schmitt RE, Arneson-Wissink PC, Ducharme AM, Bruinsma ES, Hawse JR, Jatoi A, Doles JD. A TGF-beta/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer. Proc Natl Acad Sci U S A. 2023 Aug 22; 120 (34):e2215095120 Epub 2023 Aug 16
    View PubMed
23. Wieland J, Martin N, Jatoi A. Healthcare Providers' Experiences with Hiccups in Patients with Cancer: Report of a United States National Survey. Am J Hosp Palliat Care. 2023 Aug; 40 (8):872-880 Epub 2022 Sept 29
    View PubMed
24. Hillman SL, Jatoi A, Strand CA, Perlmutter J, George S, Mandrekar SJ. Rates of and Factors Associated With Patient Withdrawal of Consent in Cancer Clinical Trials. JAMA Oncol. 2023 Aug 1; 9 (8):1041-1047
    View PubMed
25. Loprinzi CL, Novotny P, Ruddy KJ, Jatoi A, Le-Rademacher J, Ehlers SL, Cathcart-Rake E, Lee M. Measuring symptoms and toxicities: a 35-year experience. Support Care Cancer. 2023 Jul 27; 31 (8):495 Epub 2023 July 27
    View PubMed
26. Storandt MH, Rogen KR, Iyyangar A, Schnell RR, Mitchell JL, Hubbard JM, Sinicrope FA, Jatoi A, Mahipal A, Shi Q, Jin Z. Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis. Cancers (Basel). 2023 Jul 11; 15 (14) Epub 2023 July 11
    View PubMed
27. Storandt MH, Tran N, Martin N, Jatoi A. Pembrolizumab near the end of life in patients with metastatic pancreatic cancer: a multi-site consecutive series to examine survival and patient treatment burden. Cancer Immunol Immunother. 2023 Jul; 72 (7):2515-2520 Epub 2023 Mar 06
    View PubMed
28. Marell PS, Wieland J, Babiker HM, Fonkoua LK, Borad MJ, Jatoi A, Tran NH. An Overview of the Therapeutic Development of Cholangiocarcinoma with Special Emphasis on Targeted and Biologic Therapies Current Hepatology Reports. 2023; 22:1-13.
    
29. Storandt MH, Tran NH, Ehret CJ, Hanna M, Jochum J, Moynagh MR, Jatoi A. Gastrointestinal perforation after bevacizumab: a multi-site, single-institution study with a focus on survival. World J Surg Oncol. 2023 Jun 8; 21 (1):177 Epub 2023 June 08
    View PubMed
30. Bhatt VR, Ulrich AM, Uy GL, Stone RM, Stock W, Ojelabi MO, Yin J, Kohlschmidt J, Eisfeld AK, Baer MR, Chow S, Klepin H, Le-Rademacher J, Jatoi A. Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance Trials. JCO Oncol Pract. 2023 Jun; 19 (6):e877-e891 Epub 2023 Apr 14
    View PubMed
31. Polen-De C, Giri S, Fadadu P, Weaver A, Mcgree ME, Moynagh M, Takahashi N, Jatoi A, Lebrasseur NK, Cliby W, Williams G, Kumar A. Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer. J Natl Cancer Inst Monogr. 2023 May 04; 2023(61):43-48.
    View PubMed
32. Mannion S, Martin NA, O'Connor J, Wieland J, Jatoi A. In Their Own Words, "Waiting Sucks:" A Qualitative Study of Medical Testing-Related Anxiety in Patients with Cancer. Am J Hosp Palliat Care. 2023 May; 40 (5):468-474 Epub 2022 May 28
    View PubMed
33. Chaar MKA, Yost KJ, Lee MK, Chlan LL, Ghosh K, Hudspeth LA, Jatoi A, Ruddy KJ, Santore LA, Blackmon SH. Developing & integrating a mobile application tool into a survivorship clinic for esophageal cancer patients. J Thorac Dis. 2023 Apr 28; 15(4):2240-2252. Epub 2023 Apr 25.
    View PubMed
34. Tran NH, Nguyen PL, Martin NA, Asiedu G, Le-Rademacher JG, Jatoi A. "It's Like You Stuck a Pin in It:" African American/Black Patients Describe Cutaneous Toxicity From Epidermal Growth Factor Receptor Inhibitors. Am J Hosp Palliat Care. 2023 Mar; 40 (3):337-340 Epub 2022 Apr 20
    View PubMed
35. Cathcart-Rake EJ, Kling JM, Carroll EF, Davidge-Pitts C, Le-Rademacher J, Ridgeway JL, Gonzalez CA, Jatoi A. Understanding Disparities: A Case Illustrative of the Struggles Facing Transgender and Gender Diverse Patients With Cancer. J Natl Compr Canc Netw. 2023 Feb; 21 (2):227-230
    View PubMed
36. Ehret C, Martin NA, Jatoi A. What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? a compilation of patient-reported outcomes. PLoS One. 2023; 18 (1):e0280947 Epub 2023 Jan 27
    View PubMed
37. Le-Rademacher J, Mohile S, Unger J, Hudson MF, Foster J, Lichtman S, Perlmutter J, Dotan E, Extermann M, Dodd K, Tew W, Klepin H, Wildes TM, Sedrak MS, Jatoi A, Little RF. Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials. J Natl Cancer Inst Monogr. 2022 Dec 15; 2022 (60):135-141
    View PubMed
38. Ehret CJ, Le-Rademacher J, Storandt MH, Martin N, Rajotia A, Jatoi A. A randomized, double-blinded feasibility trial of educational materials for hiccups in chemotherapy-treated patients with cancer. Support Care Cancer. 2022 Dec 14; 31 (1):30
    View PubMed
39. Warsame R, Cook J, Fruth B, Hubbard J, Croghan K, Price KAR, Jatoi A, Kumar S, Thompson C, Buckner J, Dispenzieri A, Sloan J, Dueck AC. A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology. Contemp Clin Trials Commun. 2022 Oct; 29:100964 Epub 2022 July 13
    View PubMed
40. Ehret CJ, Le-Rademacher JG, Martin N, Jatoi A. Olanzapine for cisplatin-induced hiccups: observations from a 338-patient study. Ann Palliat Med. 2022 Jul; 11 (7):2314-2318 Epub 2022 Apr 24
    View PubMed
41. Ehret CJ, Almodallal Y, Le-Rademacher JG, Martin NA, Moynagh MR, Rajotia A, Jatoi A. Hiccups in patients with cancer: a multi-site, single-institution study of etiology, severity, complications, interventions, and outcomes. BMC Cancer. 2022 Jun 15; 22 (1):659 Epub 2022 June 15
    View PubMed
42. Wieland J, Jordan BL, Jatoi A. Equity. Cancer 2022 Jun 15; 128 (12):2240-2242 Epub 2022 Apr 11
    View PubMed
43. Polen-De C, Fadadu P, Weaver AL, Moynagh M, Takahashi N, Jatoi A, LeBrasseur NK, McGree M, Cliby W, Kumar A. Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer. Int J Gynecol Cancer. 2022 Jun 9 Epub 2022 June 09
    View PubMed
44. Wieland J, Almodallal Y, Martin NA, Mannion S, Nguyen P, Jatoi A. Understanding "Patient refuses" among 90+ year old patients with cancer or presumed cancer. J Geriatr Oncol. 2022 Jun; 13 (5):715-719 Epub 2022 Feb 26
    View PubMed
45. Martin NA, Hanna M, Ehret C, Asiedu G, Jatoi A. Olaparib for ovarian cancer: a single-institution, multi-site qualitative study. Support Care Cancer. 2022 Jun; 30 (6):4807-4812 Epub 2022 Feb 11
    View PubMed
46. Peil E, Williams GR, Rugo H, Woyach JA, Jatoi A, Le-Rademacher JG. Does the cancer geriatric assessment (GA) introduce bias into clinical trials? Observations from 988 prospectively recruited patients. J Geriatr Oncol. 2022 May; 13 (4):526-529 Epub 2021 Dec 15
    View PubMed
47. Brazauskas R, Jatoi A, Le-Rademacher JG. A Cautionary Tale: Grouping Patients on Late Events. Mayo Clin Proc. 2022 Mar; 97 (3):449-453 Epub 2022 Feb 05
    View PubMed
48. Gile J, Jatoi A, Wee Ma W, Borad M, Tran NH. Reply to A. Rizzo et al. JCO Precis Oncol 2022 Mar; 6:e2200061
    View PubMed
49. Kunz HE, Port JD, Kaufman KR, Jatoi A, Hart CR, Gries KJ, Lanza IR, Kumar R. Skeletal muscle mitochondrial dysfunction and muscle and whole body functional deficits in cancer patients with weight loss. J Appl Physiol (1985). 2022 Feb 1; 132 (2):388-401 Epub 2021 Dec 23
    View PubMed
50. Ehret C, Young C, Ellefson CJ, Aase LA, Jatoi A. Frequency and Symptomatology of Hiccups in Patients With Cancer: Using an On-Line Medical Community to Better Understand the Patient Experience. Am J Hosp Palliat Care. 2022 Feb; 39 (2):147-151 Epub 2021 Apr 01
    View PubMed
51. Wieland J, Satele D, Almodallal Y, Novotny P, Pritzl SL, Mandrekar SJ, Jatoi A. Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study. J Patient Exp. 2022; 9:23743735221107242 Epub 2022 June 22
    View PubMed
52. Ponde N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber RD, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart M. Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a subanalysis of the ALTTO trial (BIG 206; NCCTG (Alliance) N063D). Breast Cancer Res Treat. 2022 Jan; 191 (1):225
    View PubMed
53. VanderWalde NA, Dockter T, Wakefield DV, Satele D, Sloan J, Jagsi R, Lichtman SM, Freedman RA, Lafky JM, Muss H, Cohen HJ, Le-Rademacher J, Jatoi A. Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736). J Geriatr Oncol. 2022 Jan; 13 (1):20-26 Epub 2021 Aug 04
    View PubMed
54. Wieland J, Jordan BL, Jatoi A. Equity. Cancer (0008543X). 2022; 128(12):2240-2.
    
55. Ehret CJ, Jatoi A. Establishing the groundwork for clinical trials with Hiccupops (R) for hiccup palliation. American Journal of Hospice and Palliative Medicine. 2022; 39 (10):1210-4
    
56. Duong Q, Mandrekar SJ, Winham SJ, Cook K, Jatoi A, Le-Rademacher JG. Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical Trials. J Cancer Educ. 2021 Dec; 36 (6):1248-1252
    View PubMed
57. Sexton M, Garcia JM, Jatoi A, Clark CS, Wallace MS. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. J Natl Cancer Inst Monogr. 2021 Nov 28; 2021 (58):86-98
    View PubMed
58. Almodallal Y, Cook K, Lammert LM, Lee M, Le-Rademacher JG, Jatoi A. Can older patients adopt and maintain a ketogenic diet? An observational study in support of clinical trials in older patients. Medicine (Baltimore). 2021 Nov 24; 100 (47):e28033
    View PubMed
59. Almodallal Y, Cook KD, Mannion S, Hanna M, Martin NA, Nguyen PL, Jatoi A. Metastatic or suspected metastatic cancer in patients 90 years of age or older: A single-institution, multi-site study. J Geriatr Oncol. 2021 Nov; 12 (8):1220-1224 Epub 2021 Mar 31
    View PubMed
60. Almodallal Y, Duong Q, Satele D, Novotny P, Cook KD, Chauhan C, Daiss MK, Le-Rademacher J, Looker S, Martin N, Smestad MF, Winham SJ, Mandrekar SJ, Jatoi A. Randomized, Double-Blind Trial on the Impact of Word Count in Cancer Clinical Trial Consent Forms. JCO Oncol Pract. 2021 Oct; 17 (10):e1460-e1472 Epub 2021 June 14
    View PubMed
61. Cook K, Almodallal Y, Martin N, Jatoi A. Alpelisib-induced hyperglycemia in older patients with breast Cancer: Qualitative findings. J Geriatr Oncol 2021 Sep; 12 (7):1114-1117 Epub 2021 Mar 19
    View PubMed
62. Smith CJ, Almodallal Y, Jatoi A. Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review. Curr Oncol Rep. 2021 Jul 1; 23 (8):98 Epub 2021 July 01
    View PubMed
63. Almodallal Y, Le-Rademacher JG, Cook KD, Yadav S, Singh AB, Lee M, Lammert LM, Jatoi A. Observations with alpelisib in older patients (>/= 65 year of age) with breast cancer in a non-clinical trial setting. Breast Cancer Res Treat. 2021 Jul; 188 (1):15-20 Epub 2021 June 12
    View PubMed
64. Jatoi A, Ou FS, Ahn DH, Zemla TJ, Le-Rademacher JG, Boland P, Ciombor KK, Jacobs NL, Pasche B, Cleary JM, McCune JS, Pedersen KS, Barzi A, Chiorean EG, Heying EN, Lenz HJ, Sloan JA, Grothey A, Lacouture ME, Bekaii-Saab T. Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial. Oncologist. 2021 Jul; 26 (7):610-618 Epub 2021 Mar 06
    View PubMed
65. Smith CJ, Almodallal Y, Jatoi A. Rare Adverse Events with Programmed Death-1 and Programmed Death-1 Ligand Inhibitors: Justification and Rationale for a Systematic Review. Curr Oncol Rep. 2021 May 26; 23 (7):86
    View PubMed
66. Maggiore RJ, Zahrieh D, McMurray RP, Feliciano JL, Samson P, Mohindra P, Chen H, Wong ML, Lafky JM, Jatoi A, Le-Rademacher JG. Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812). J Geriatr Oncol. 2021 May; 12 (4):563-571 Epub 2020 Sept 16
    View PubMed
67. Polen-De C, Langstraat C, Asiedu GB, Jatoi A, Kumar A. Advanced ovarian cancer patients identify opportunities for prehabilitation: A qualitative study. Gynecol Oncol Rep. 2021 May; 36:100731 Epub 2021 Feb 19
    View PubMed
68. Tao J, Jatoi A, Crawford J, Lam WWT, Ho JC, Wang X, Pang H. Role of dietary carbohydrates on risk of lung cancer. Lung Cancer. 2021 May; 155:87-93 Epub 2021 Mar 17
    View PubMed
69. Guerard E, Dodge AB, Le-Rademacher JG, Kemeny MM, Ojelabi M, Sedrak MS, Hopkins J, Shahrokni A, Harlos E, Muss H, Cohen HJ, Lafky J, Sloan J, Jatoi A, Hurria A. Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603). JCO Clin Cancer Inform. 2021 Apr; 5:435-441
    View PubMed
70. Martin NA, Harlos ES, Cook KD, O'Connor JM, Dodge A, Guerard E, Lafky JM, Jatoi A, Le-Rademacher JG. How Did a Multi-Institutional Trial Show Feasibility of Electronic Data Capture in Older Patients With Cancer? Results From a Multi-Institutional Qualitative Study (Alliance A171902). JCO Clin Cancer Inform. 2021 Apr; 5:442-449
    View PubMed
71. Wong ML, Gao J, Thanarajasingam G, Sloan JA, Dueck AC, Novotny PJ, Jatoi A, Hurria A, Walter LC, Miaskowski C, Cohen HJ, Wood WA, Feliciano JL, Stinchcombe TE, Wang X. Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729). Oncologist. 2021 Mar; 26 (3):e435-e444 Epub 2020 Oct 01
    View PubMed
72. Moynagh MR, Dowdy SC, Welch B, Glaser GE, Schmitz JJ, Jatoi A, Langstraat CL, Block MS, Kurup AN, Kumar A. Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program. Gynecol Oncol. 2021 Mar; 160 (3):835-843 Epub 2020 Dec 30
    View PubMed
73. Smith CJ, Bekaii-Saab TS, Cook KD, Eiring RA, Halfdanarson TR, Hanna M, Jin Z, Jochum JA, Ma WW, Mitchell JL, Pitot HC, Jatoi A. Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer. Pancreatology. 2021 Mar; 21 (2):379-383 Epub 2020 Oct 18
    View PubMed
74. Ehret C, Jatoi A. Should Loss of Appetite Be Palliated in Patients with Advanced Cancer? Curr Treat Options Oncol. 2021 Feb 27; 22 (4):31
    View PubMed
75. Childs DS, Yoon HH, Eiring RA, Jin Z, Jochum JA, Pitot HC, Jatoi A. Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer. Support Care Cancer. 2021 Feb; 29 (2):733-739 Epub 2020 May 24
    View PubMed
76. Gile JJ, Ou FS, Mahipal A, Larson JJ, Mody K, Jin Z, Hubbard J, Halfdanarson T, Alberts SR, Jatoi A, McWilliams RR, Ma WW, Ilyas S, Smoot R, Roberts L, Gores G, Borad M, Bekaii-Saab TS, Tran NH. FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience. JCO Precis Oncol. 2021; 5 Epub 2021 July 28
    View PubMed
77. Ponde N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber RD, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart M. Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D). Breast Cancer Res Treat. 2021 Jan; 185 (1):107-116 Epub 2020 Sept 19
    View PubMed
78. Sedrak MS, Freedman RA, Cohen HJ, Muss HB, Jatoi A, Klepin HD, Wildes TM, Le-Rademacher JG, Kimmick GG, Tew WP, George K, Padam S, Liu J, Wong AR, Lynch A, Djulbegovic B, Mohile SG, Dale W, Cancer and Aging Research Group (CARG). Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. CA Cancer J Clin. 2021 Jan; 71 (1):78-92 Epub 2020 Oct 01
    View PubMed
79. Antwi SO, Bamlet WR, Cawthon RM, Rabe KG, Druliner BR, Sicotte H, Jatoi A, Mahipal A, Boardman LA, Oberg AL, Petersen GM. Shorter Treatment-Naive Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2021 Jan; 30 (1):210-216 Epub 2020 Nov 13
    View PubMed
80. Kunz HE, Dorschner JM, Berent TE, Meyer T, Wang X, Jatoi A, Kumar R, Lanza IR. Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting. J Biol Chem. 2020 Dec 18; 295 (51):17441-17459
    View PubMed
81. Cathcart-Rake E, O'Connor J, Ridgeway JL, Breitkopf CR, Kaur JS, Mitchell J, Leventakos K, Jatoi A. Patients' Perspectives and Advice on How to Discuss Sexual Orientation, Gender Identity, and Sexual Health in Oncology Clinics. Am J Hosp Palliat Care. 2020 Dec; 37 (12):1053-1061 Epub 2020 Mar 26
    View PubMed
82. Le-Rademacher J, Lopez C, Wolfe E, Foster NR, Mandrekar SJ, Wang X, Kumar R, Adjei A, Jatoi A. Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients. J Cachexia Sarcopenia Muscle. 2020 Dec; 11 (6):1501-1508 Epub 2020 Sept 17
    View PubMed
83. Laird BJA, Jatoi A. Editorial: Cancer cachexia - bridging the gap. Curr Opin Support Palliat Care 2020 Dec; 14 (4):301
    View PubMed
84. Le-Rademacher JG, Jatoi A. Editorial: What about weight? Advocating for simplicity in cancer cachexia trials. Curr Opin Support Palliat Care 2020 Dec; 14 (4):302-303
    View PubMed
85. Almodallal Y, Lee MK, Le-Rademacher JG, Smith CJ, Carroll JL, Robinson SI, Jatoi A. Non-Squamous, Non-Basal Cell Cancers of the Skin: Exploring Associations Between Site of Disease and Depression. Am J Hosp Palliat Care. 2020 Nov 15; 1049909120969605 [Epub ahead of print]
    View PubMed
86. Le-Rademacher JG, Hillman S, Storrick E, Mahoney MR, Thall PF, Jatoi A, Mandrekar SJ. Adverse Event Burden Score-A Versatile Summary Measure for Cancer Clinical Trials. Cancers (Basel). 2020 Nov 4; 12 (11) Epub 2020 Nov 04
    View PubMed
87. Xie H, Liu J, Yin J, Ogden JR, Mahipal A, McWilliams RR, Truty MJ, Bekaii-Saab TS, Petersen GM, Jatoi A, Hubbard JM, Ma WW. Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. Oncologist. 2020 Nov; 25 (11):e1681-e1690 Epub 2020 Aug 04
    View PubMed
88. Block MS, Dietz AB, Gustafson MP, Kalli KR, Erskine CL, Youssef B, Vijay GV, Allred JB, Pavelko KD, Strausbauch MA, Lin Y, Grudem ME, Jatoi A, Klampe CM, Wahner-Hendrickson AE, Weroha SJ, Glaser GE, Kumar A, Langstraat CL, Solseth ML, Deeds MC, Knutson KL, Cannon MJ. Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients. Nat Commun. 2020 Oct 14; 11(1):5173.
    View PubMed
89. Laird BJA, Jatoi A. Cancer cachexia - bridging the gap. Curr Opin Support Palliat Care. 2020 Oct 13 [Epub ahead of print]
    View PubMed
90. Sheehan MT, Wermers RA, Jatoi A, Loprinzi CL, Onitilo AA. Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy. Med Hypotheses. 2020 Oct; 143:110149 Epub 2020 July 30
    View PubMed
91. Kunz HE, Dorschner JM, Berent TE, Meyer T, Wang X, Jatoi A, Kumar R, Lanza IR. Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting. J Biol Chem. 2020 Oct 1 Epub 2020 Oct 01
    View PubMed
92. Colon-Otero G, Zanfagnin V, Hou X, Foster NR, Asmus EJ, Wahner Hendrickson A, Jatoi A, Block MS, Langstraat CL, Glaser GE, Dinh TA, Robertson MW, Camoriano JK, Butler KA, Copland JA, Weroha SJ. Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers. ESMO Open. 2020 Oct; 5(5):e000926.
    View PubMed
93. Piderman KM, Radecki Breitkopf C, Jenkins SM, Ingram C, Sytsma TT, Lapid MI, Tata BS, Chatterjee K, Egginton JS, Jatoi A. Hearing and Heeding the Voices of those With Advanced Illnesses. J Palliat Care. 2020 Oct; 35 (4):248-255 Epub 2020 May 28
    View PubMed
94. Narasimhulu DM, McGree ME, Weaver AL, Jatoi A, LeBrasseur NK, Glaser GE, Langstraat CL, Block MS, Kumar A. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer. Gynecol Oncol. 2020 Sep; 158 (3):646-652 Epub 2020 June 06
    View PubMed
95. Xie H, Liu J, Ogden JR, Yin J, Jatoi A, Hubbard JM, McWilliams RR, Mahipal A, Petersen GM, Bekaii-Saab TS, Ma WW. Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. Am J Clin Oncol. 2020 Aug; 43 (8):586-590
    View PubMed
96. Khera N, Kumbamu A, Langer SL, Jatoi A, Kamath CC, Mathew E, Zafar YS, Griffin JM. Developing an Educational Intervention to Address Financial Hardship in Cancer Patients. Mayo Clin Proc Innov Qual Outcomes. 2020 Aug; 4 (4):424-433 Epub 2020 July 15
    View PubMed
97. Antwi SO, Bamlet WR, Rabe KG, Cawthon RM, Umudi I, Druliner BR, Sicotte H, Oberg AL, Jatoi A, Boardman LA, Petersen GM. Leukocyte Telomere Length and Its Interaction with Germline Variation in Telomere-Related Genes in Relation to Pancreatic Adenocarcinoma Risk. Cancer Epidemiol Biomarkers Prev. 2020 Jul; 29 (7):1492-1500 Epub 2020 Apr 20
    View PubMed
98. Arneson PC, Arneson-Wissink PC, Hogan KA, Ducharme AM, Samani A, Jatoi A, Doles JD. The wasting-associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration. JCSM Rapid Commun. 2020 Jul-Dec; 3 (2):56-69 Epub 2020 June 02
    View PubMed
99. Stout J, Kumbamu A, Tilburt J, Fernandez C, Geller G, Koenig B, Lenz HJ, Jatoi A. Conversations on Cancer Chemotherapy Cessation in Patients With Advanced Cancer: Qualitative Findings From a Multi-Institutional Study. Am J Hosp Palliat Care. 2020 Jun 4; 1049909120930710 Epub 2020 June 04
    View PubMed
100. Cathcart-Rake E, O'Connor JM, Ridgeway JL, Breitkopf CR, Guire LJM, Olson EA, Kaur JS, Leventakos K, Jatoi A. Querying Patients With Cancer About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Health-Care Providers. Am J Hosp Palliat Care. 2020 Jun; 37 (6):418-423 Epub 2019 Oct 10
     View PubMed
101. Cathcart-Rake E, O'Connor JM, Jacobson A, McGuire L, Jatoi A. How (and why) to ask the older cancer patient about sexual health and sexual minority status. J Geriatr Oncol. 2020 May; 11 (4):576-578 Epub 2019 Aug 22
     View PubMed
102. Elias R, Loh KP, Targia V, Whitehead M, Canin B, Jatoi A, Loscalzo M, Mohile S. Behavioral, psychological, and supportive care interventions in geriatric oncology: The Cancer and Aging Research Group infrastructure core. J Geriatr Oncol. 2020 Mar; 11 (2):347-349 Epub 2019 Aug 02
     View PubMed
103. Smith C, Hendrickson AW, Grudem M, Klampe C, Deering E, Jatoi A. Loratadine for Paclitaxel-Induced Myalgias and Arthralgias. Am J Hosp Palliat Care. 2020 Mar; 37 (3):235-238 Epub 2019 July 17
     View PubMed
104. Karuturi MS, Sedrak MS, Magnuson A, Freedman R, Jatoi A, Smith BD, Kimmick GG. Breast cancer and aging: Standing on the shoulders of a giant. J Geriatr Oncol. 2020 Mar; 11 (2):212-216 Epub 2019 June 11
     View PubMed
105. Dao D, O'Connor JM, Jatoi A, Ridgeway J, Deering E, Schwecke A, Breitkopf CR, Huston O, Le-Rademacher JG. A qualitative study of healthcare-related experiences of non-smoking women with lung cancer. Support Care Cancer. 2020 Jan; 28 (1):123-130 Epub 2019 Apr 15
     View PubMed
106. McCleary-Wheeler AL, Carr RM, Palmer SR, Smyrk TC, Allred JB, Almada LL, Tolosa EJ, Lamberti MJ, Marks DL, Borad MJ, Molina JR, Qi Y, Lingle WL, Grothey A, Pitot HC, Jatoi A, Northfelt DW, Bryce AH, McWilliams RR, Okuno SH, Haluska P, Kim GP, Colon-Otero G, Lowe VJ, Callstrom MR, Ma WW, Bekaii-Saab T, Hung MC, Erlichman C, Fernandez-Zapico ME. Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer. Pancreatology. 2020 Jan; 20 (1):101-109 Epub 2019 Nov 21
     View PubMed
107. Hendrix K, Wilson D, Kievman MJ, Jatoi A. Perspectives on the Medical, Quality of Life, and Economic Consequences of Hiccups. Curr Oncol Rep. 2019 Dec 19; 21 (12):113
     View PubMed
108. Le-Rademacher JG, Storrick EM, Jatoi A. Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss. J Cachexia Sarcopenia Muscle. 2019 Dec; 10 (6):1175-1182 Epub 2019 Aug 20
     View PubMed
109. Jatoi A, Laird BJA. Editorial: Merging therapeutics and supportive care: synergy and yield. Curr Opin Support Palliat Care 2019 Dec; 13 (4):277-278
     View PubMed
110. Al-Refaie WB, Decker PA, Ballman KV, Pisters PWT, Posner MC, Hunt KK, Meyers B, Weinberg AD, Nelson H, Newman L, Tan A, Le-Rademacher JG, Hurria A, Jatoi A. Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol. 2019 Dec; 26 (13):4213-4221 Epub 2019 Oct 11
     View PubMed
111. Dunne RF, Loh KP, Williams GR, Jatoi A, Mustian KM, Mohile SG. Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review. Cancers (Basel). 2019 Nov 25; 11 (12)
     View PubMed
112. Ustun C, Le-Rademacher J, Wang HL, Othus M, Sun Z, Major B, Zhang MJ, Storrick E, Lafky JM, Chow S, Mrozek K, Attar EC, Nand S, Bloomfield CD, Cripe LD, Tallman MS, Appelbaum F, Larson RA, Marcucci G, Roboz GJ, Uy GL, Stone RM, Jatoi A, Shea TC, de Lima M, Foran JM, Sandmaier BM, Litzow MR, Erba HP, Hurria A, Weisdorf DJ, Artz AS. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Leukemia. 2019 Nov; 33 (11):2599-2609 Epub 2019 May 09
     View PubMed
113. Tilburt J, Yost KJ, Lenz HJ, Zúñiga ML, O'Byrne T, Branda ME, Leppin AL, Kimball B, Fernandez C, Jatoi A, Barwise A, Kumbamu A, Montori V, Koenig BA, Geller G, Larson S, Roter DL. A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context. Oncologist. 2019 Nov; 24(11):e1180-e1189. Epub 2019 May 17.
     View PubMed
114. Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD. Sarcopenia: A Time for Action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle. 2019 Oct; 10 (5):956-961 Epub 2019 Sept 15
     View PubMed
115. Muss HB, Polley MC, Berry DA, Liu H, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Kartcheske PA, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Sutton LM, Magrinat G, Parker BA, Hart RD, Grenier D, Hurria A, Jatoi A, Norton L, Hudis CA, Winer EP, Carey L. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 Sep 10; 37 (26):2338-2348 Epub 2019 July 24
     View PubMed
116. Balko R, Hurley R, Jatoi A. Poly (ADP-Ribose) Polymerase Inhibition for Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Placebo-Controlled Trials. J Palliat Med. 2019 Aug; 22 (8):977-980 Epub 2019 Mar 06
     View PubMed
117. Warsame R, Kennedy CC, Kumbamu A, Branda M, Fernandez C, Kimball B, Leppin AL, O'Byrne T, Jatoi A, Lenz HJ, Tilburt JC. Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study. J Oncol Pract. 2019 Aug; 15(8):e690-e703. Epub 2019 Jun 04.
     View PubMed
118. Cathcart-Rake EJ, Breitkopf CR, Kaur J, O'Connor J, Ridgeway JL, Jatoi A. Teaching Health-Care Providers to Query Patients With Cancer About Sexual and Gender Minority (SGM) Status and Sexual Health. Am J Hosp Palliat Care. 2019 Jun; 36 (6):533-537 Epub 2019 Jan 01
     View PubMed
119. Le-Rademacher JG, Rowland K, Atherton PJ, Dakhil C, Sun Z, Tan A, Schmidt L, Nguyen PL, Radecki Breitkopf C, Pittelkow M, Tindall D, Menon S, Jatoi A. Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series. Am J Hosp Palliat Care. 2019 Jun; 36 (6):519-525 Epub 2019 Jan 02
     View PubMed
120. Le-Rademacher JG, Storrick EM, Jatoi A, Mandrekar SJ. Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials. Mayo Clin Proc Innov Qual Outcomes. 2019 Jun; 3 (2):176-182 Epub 2019 May 27
     View PubMed
121. Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JG. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715). Oncologist. 2019 Jun; 24 (6):e284-e291 Epub 2019 Apr 11
     View PubMed
122. Hurria A, Soto-Perez-de-Celis E, Allred JB, Cohen HJ, Arsenyan A, Ballman K, Le-Rademacher J, Jatoi A, Filo J, Mandelblatt J, Lafky JM, Kimmick G, Klepin HD, Freedman RA, Burstein H, Gralow J, Wolff AC, Magrinat G, Barginear M, Muss H. Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer. J Am Geriatr Soc. 2019 May; 67 (5):920-927 Epub 2018 Aug 26
     View PubMed
123. Dunne RF, Roussel B, Culakova E, Pandya C, Fleming FJ, Hensley B, Magnuson AM, Loh KP, Gilles M, Ramsdale E, Maggiore RJ, Jatoi A, Mustian KM, Dale W, Mohile SG. Characterizing cancer cachexia in the geriatric oncology population. J Geriatr Oncol. 2019 May; 10 (3):415-419 Epub 2018 Sept 05
     View PubMed
124. Barginear M, Dueck AC, Allred JB, Bunnell C, Cohen HJ, Freedman RA, Hurria A, Kimmick G, Le-Rademacher JG, Lichtman S, Muss HB, Shulman LN, Copur MS, Biggs D, Ramaswamy B, Lafky JM, Jatoi A. Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101. Oncologist. 2019 May; 24 (5):617-623 Epub 2018 Nov 08
     View PubMed
125. Cathcart-Rake EJ, Zemla T, Jatoi A, Weaver KE, Neuman H, Kazak AE, Carlos R, Gansauer L, Unger JM, Pajewski NM, Kamen C. Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups. Cancer. 2019 Apr 15; 125 (8):1313-1318 Epub 2018 Dec 18
     View PubMed
126. Leventakos K, Schwecke AJ, Deering E, Cathcart-Rake E, Sanh AC, Jatoi A. The Need to Prioritize and Re-prioritize Palliative Care Options: Smoking Cessation as a Case-in-Point. Curr Treat Options Oncol. 2019 Mar 22; 20 (4):33
     View PubMed
127. Dao D, O’Connor JM, Jatoi A, Ridgeway J, Deering E, Schwecke A, Radecki C, Huston O, Le-Rademacher JG. A Qualitative Study of Health Care-Related Experiences of Lung Cancer in Non-Smoking Women Supportive Care Cancer - accepted. 2019.
     
128. Anker MS, Holcomb R, Muscaritoli M, von Haehling S, Haverkamp W, Jatoi A, Morley JE, Strasser F, Landmesser U, Coats AJS, Anker SD. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle. 2019 Feb; 10 (1):22-34
     View PubMed
129. Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, Liu M, Xu C, Zhang Q, Zhu H, Yan J, Zhu VF, Luo Y, Hagan JP, Li Z, Fang J, Jatoi A, Fernandez-Zapico ME, Zheng L, Edil BH, Bronze MS, Houchen CW, Li YP, Li M. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells. Gastroenterology. 2019 Feb; 156 (3):722-734.e6 Epub 2018 Oct 17
     View PubMed
130. Childs DS, Looker S, Le-Rademacher J, Ridgeway JL, Breitkopf CR, Jatoi A. What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study. Support Care Cancer. 2019 Jan; 27 (1):249-255 Epub 2018 June 25
     View PubMed
131. Balko RA, Hendrickson AW, Grudem ME, Klampe CM, Jatoi A. Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer? Am J Hosp Palliat Care. 2019 Jan; 36 (1):72-75 Epub 2018 July 08
     View PubMed
132. Childs DS, Jatoi A. A hunger for hunger: a review of palliative therapies for cancer-associated anorexia. Ann Palliat Med. 2019 Jan; 8 (1):50-58 Epub 2018 May 24
     View PubMed
133. Berent TE, Dorschner JM, Meyer T, Craig TA, Wang X, Kunz H, Jatoi A, Lanza IR, Chen H, Kumar R. Impaired cardiac performance, protein synthesis, and mitochondrial function in tumor-bearing mice. PLoS One. 2019; 14 (12):e0226440 Epub 2019 Dec 18
     View PubMed
134. Laird BJA, Jatoi A. 'The shoulders, clavicles, chest and thighs melt away': a compilation of reviews on cachexia. Curr Opin Support Palliat Care 2018 Dec; 12 (4):393
     View PubMed
135. Asiedu GB, Ridgeway JL, Carroll K, Jatoi A, Radecki Breitkopf C. "Ultimately, mom has the call": Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy. Health Expect. 2018 Dec; 21 (6):981-989 Epub 2018 Apr 14
     View PubMed
136. Bartlett DJ, Childs DS, Breitkopf CR, Grudem ME, Mitchell JL, Looker SA, Ridgeway JL, Lee JL, Butterfield JH, Weroha SJ, Jatoi A. Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer. Am J Hosp Palliat Care. 2018 Nov; 35 (11):1384-1389 Epub 2018 May 03
     View PubMed
137. Cathcart-Rake E, Smith D, Zahrieh D, Jatoi A, Yang P, Loprinzi CL. Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment? Support Care Cancer. 2018 Nov; 26 (11):3909-3914 Epub 2018 May 24
     View PubMed
138. Freedman RA, Dockter TJ, Lafky JM, Hurria A, Muss HJ, Cohen HJ, Jatoi A, Kemeny MM, Ruddy KJ. Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602). Oncologist. 2018 Sep; 23 (9):1016-1023 Epub 2018 Apr 19
     View PubMed
139. Feliciano JL, Le-Rademacher JG, Gajra A, Edelman MJ, Zemla T, McMurray R, Chen H, Hurria A, Muss H, Cohen HJ, Lilenbaum R, Jatoi A. Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622). J Geriatr Oncol. 2018 Sep; 9 (5):501-506 Epub 2018 May 27
     View PubMed
140. Doles JD, Hogan KA, O'Connor J, Wahner Hendrickson AE, Huston O, Jatoi A. Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients. J Palliat Med. 2018 Sep; 21 (9):1334-1338 Epub 2018 May 24
     View PubMed
141. Li D, McCall LM, Hahn OM, Hudis CA, Cohen HJ, Muss HB, Jatoi A, Lafky JM, Ballman KV, Winer EP, Tripathy D, Schneider B, Barry W, Dickler MN, Hurria A. Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study. Breast Cancer Res Treat. 2018 Sep; 171 (2):325-334 Epub 2018 May 22
     View PubMed
142. Cole CL, Kleckner IR, Jatoi A, Schwarz EM, Dunne RF. The Role of Systemic Inflammation in Cancer-Associated Muscle Wasting and Rationale for Exercise as a Therapeutic Intervention. JCSM Clin Rep. 2018 Jul-Dec; 3 (2)
     View PubMed
143. Gajra A, Zemla TJ, Jatoi A, Feliciano JL, Wong ML, Chen H, Maggiore R, McMurray RP, Hurria A, Muss HB, Cohen HJ, Lafky J, Edelman MJ, Lilenbaum R, Le-Rademacher JG. Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711). J Thorac Oncol. 2018 Jul; 13 (7):996-1003 Epub 2018 Mar 30
     View PubMed
144. Tallarico M, Foster JC, Seisler D, Lafky JM, Hurria A, Jatoi A, Cohen HJ, Muss HB, Bartlett N, Cheson BD, Jung SH, Leonard JP, Byrd JC, Nabhan C. Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611). J Geriatr Oncol. 2018 Jul; 9 (4):321-328 Epub 2018 Apr 17
     View PubMed
145. Kimball BC, Geller G, Warsame R, Kumbamu A, Jatoi A, Koenig B, Tilburt JC. Looking Back, Looking Forward: The Ethical Framing of Complementary and Alternative Medicine in Oncology Over the Last 20 Years. Oncologist 2018 Jun; 23 (6):639-641 Epub 2018 Mar 09
     View PubMed
146. Xie D, Allen MS, Marks R, Jiang G, Sun Z, Nichols F, Zhang M, Chen C, Aubry MC, Jatoi A, Garces YI, Mansfield A, Wigle D, Molina J, Deschamps C, Yang P. Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers. Eur J Cardiothorac Surg. 2018 Jun 1; 53 (6):1214-1222
     View PubMed
147. Lacouture ME, Anadkat M, Jatoi A, Garawin T, Bohac C, Mitchell E. Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review. Clin Colorectal Cancer. 2018 Jun; 17 (2):85-96 Epub 2017 Dec 13
     View PubMed
148. Gajra A, McCall L, Muss HB, Cohen HJ, Jatoi A, Ballman KV, Partridge AH, Sutton L, Parker BA, Magrinat G, Klepin HD, Lafky JM, Hurria A. The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance). J Geriatr Oncol. 2018 May; 9 (3):221-227 Epub 2018 Mar 28
     View PubMed
149. Morrison VA, McCall L, Muss HB, Jatoi A, Cohen HJ, Cirrincione CT, Ligibel JA, Lafky JM, Hurria A. The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436). J Geriatr Oncol. 2018 May; 9 (3):228-234 Epub 2017 Dec 08
     View PubMed
150. Cathcart-Rake EJ, Lightner DJ, Quevedo FJ, Ertz DC, Jatoi A. Cancer in Transgender Patients: One Case in 385,820 Is Indicative of a Paucity of Data. J Oncol Pract. 2018 Apr; 14 (4):270-272 Epub 2017 Dec 19
     View PubMed
151. Gannavarapu BS, Lau SKM, Carter K, Cannon NA, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R, Iyengar P. Prevalence and Survival Impact of Pretreatment Cancer-Associated Weight Loss: A Tool for Guiding Early Palliative Care. J Oncol Pract. 2018 Apr; 14 (4):e238-e250 Epub 2018 Feb 21
     View PubMed
152. Lau SKM, Gannavarapu BS, Carter K, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R, Iyengar P. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer. J Oncol Pract. 2018 Apr; 14 (4):e211-e220 Epub 2018 Mar 20
     View PubMed
153. Yusuf N, Jatoi A. Cancer-associated weight loss: releasing its firm grip on negative clinical outcomes. Curr Opin Support Palliat Care 2017 Dec; 11 (4):259-260
     View PubMed
154. Hopkins JO, Allred J, Hurria A, Jatoi A, Lafky JM, Cohen H, Hudis C, Winer E, Mandelblatt J, Partridge A, Carey L, Muss HB. Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302). Breast Cancer Res Treat. 2017 Dec; 166 (3):793-808 Epub 2017 Aug 20
     View PubMed
155. Foster JC, Le-Rademacher JG, Feliciano JL, Gajra A, Seisler DK, DeMatteo R, Lafky JM, Hurria A, Muss HB, Cohen HJ, Jatoi A. Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort. Cancer. 2017 Nov 1; 123 (21):4193-4198 Epub 2017 July 12
     View PubMed
156. Carr RM, Enriquez-Hesles E, Olson RL, Jatoi A, Doles J, Fernandez-Zapico ME. Epigenetics of cancer-associated muscle catabolism. Epigenomics 2017 Oct; 9 (10):1259-1265 Epub 2017 Sept 25
     View PubMed
157. McWilliams RR, Foster NR, Mahoney MR, Smyrk TC, Murray JA, Ames MM, Horvath LE, Schneider DJ, Schneider DJ, Hobday TJ, Jatoi A, Meyers JP, Goetz MP. North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. Cancer. 2017 Sep 15; 123 (18):3494-3501 Epub 2017 May 10
     View PubMed
158. Le-Rademacher JG, Crawford J, Evans WJ, Jatoi A. Overcoming obstacles in the design of cancer anorexia/weight loss trials. Crit Rev Oncol Hematol. 2017 Sep; 117:30-37 Epub 2017 June 24
     View PubMed
159. Shin JY, Kizilbash SH, Robinson S, Uhm JH, Jatoi A. Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma. Am J Hosp Palliat Care. 2017 Aug; 34 (7):650-653 Epub 2016 May 05
     View PubMed
160. Jatoi A, Steen PD, Atherton PJ, Moore DF, Rowland KM, Le-Lindqwister NA, Adonizio CS, Jaslowski AJ, Sloan J, Loprinzi C. A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. Ann Oncol. 2017 Aug 1; 28 (8):1957-1963
     View PubMed
161. Colon-Otero G, Weroha SJ, Foster NR, Haluska P, Hou X, Wahner-Hendrickson AE, Jatoi A, Block MS, Dinh TA, Robertson MW, Copland JA. Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers. Gynecol Oncol. 2017 Jul; 146(1):64-68. Epub 2017 Apr 28.
     View PubMed
162. Antwi SO, Bamlet WR, Broderick BT, Chaffee KG, Oberg A, Jatoi A, Boardman LA, Petersen GM. Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2017 Jun; 26 (6):971-974 Epub 2017 Mar 06
     View PubMed
163. Kimmick GG, Major B, Clapp J, Sloan J, Pitcher B, Ballman K, Barginear M, Freedman RA, Artz A, Klepin HD, Lafky JM, Hopkins J, Winer E, Hudis C, Muss H, Cohen H, Jatoi A, Hurria A, Mandelblatt J. Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Res Treat. 2017 Jun; 163 (2):391-398 Epub 2017 Mar 10
     View PubMed
164. Mehner C, Oberg AL, Goergen KM, Kalli KR, Maurer MJ, Nassar A, Goode EL, Keeney GL, Jatoi A, Radisky DC, Radisky ES. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review. Genes Cancer. 2017 May; 8 (5-6):589-599
     View PubMed
165. Kim DW, Garon EB, Jatoi A, Keefe DM, Lacouture ME, Sonis S, Gernhardt D, Wang T, Giri N, Doherty JP, Nadanaciva S, O'Connell J, Sbar E, Cho BC. Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042). Lung Cancer. 2017 Apr; 106:76-82 Epub 2017 Feb 01
     View PubMed
166. Jatoi A, Grudem ME, Dockter TJ, Block MS, Villasboas JC, Tan A, Deering E, Kasi PM, Mansfield AS, Botero JP, Okuno SH, Smith DR, Fields AP. A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome. Support Care Cancer. 2017 Mar; 25(3):833-838. Epub 2016 Nov 12.
     View PubMed
167. Piderman KM, Radecki Breitkopf C, Jenkins SM, Lapid MI, Kwete GM, Sytsma TT, Lovejoy LA, Yoder TJ, Jatoi A. The impact of a spiritual legacy intervention in patients with brain cancers and other neurologic illnesses and their support persons. Psychooncology. 2017 Mar; 26(3):346-353. Epub 2015 Dec 07.
     View PubMed
168. Ridgeway JL, Asiedu GB, Carroll K, Tenney M, Jatoi A, Radecki Breitkopf C. Patient and family member perspectives on searching for cancer clinical trials: A qualitative interview study. Patient Educ Couns. 2017 Feb; 100 (2):349-354 Epub 2016 Aug 22
     View PubMed
169. Freedman RA, Foster JC, Seisler DK, Lafky JM, Muss HB, Cohen HJ, Mandelblatt J, Winer EP, Hudis CA, Partridge AH, Carey LA, Cirrincione C, Moreno-Aspitia A, Kimmick G, Jatoi A, Hurria A. Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527. J Clin Oncol. 2017 Feb; 35 (4):421-431 Epub 2016 Dec 19
     View PubMed
170. Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 Jan; 161 (2):363-373 Epub 2016 Nov 19
     View PubMed
171. Piderman KM, Egginton JS, Ingram C, Dose AM, Yoder TJ, Lovejoy LA, Swanson SW, Hogg JT, Lapid MI, Jatoi A, Remtema MS, Tata BS, Breitkopf CR. I'm Still Me: Inspiration and Instruction from Individuals with Brain Cancer. J Health Care Chaplain. 2017 Jan-Mar; 23 (1):15-33 Epub 2016 July 11
     View PubMed
172. Egan JB, Marks DL, Hogenson TL, Vrabel AM, Sigafoos AN, Tolosa EJ, Carr RM, Safgren SL, Hesles EE, Almada LL, Romecin-Duran PA, Iguchi E, Ala'Aldeen A, Kocher JA, Oliver GR, Prodduturi N, Mead DW, Hossain A, Huneke NE, Tagtow CM, Ailawadhi S, Ansell SM, Banck MS, Bryce AH, Carballido EM, Chanan-Khan AA, Curtis KK, Resnik E, Gawryletz CD, Go RS, Halfdanarson TR, Ho TH, Joseph RW, Kapoor P, Mansfield AS, Meurice N, Nageswara Rao AA, Nowakowski GS, Pardanani A, Parikh SA, Cheville JC, Feldman AL, Ramanathan RK, Robinson SI, Tibes R, Finnes HD, McCormick JB, McWilliams RR, Jatoi A, Patnaik MM, Silva AC, Wieben ED, McAllister TM, Rumilla KM, Kerr SE, Lazaridis KN, Farrugia G, Stewart AK, Clark KJ, Kennedy EJ, Klee EW, Borad MJ, Fernandez-Zapico ME. Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma. JCO Precis Oncol. 2017; 2017 Epub 2017 Aug 01
     View PubMed
173. Childs DS, Jacobson AC, Mitchell JL, Hubbard JM, Yoon HH, Finnes H, Grothey A, Jatoi A. Prescriber adherence to antiemetic guidelines with the new agent trifuridine-tipiracil Journal of Community and Supportive Oncology. 2017; 15: (3)e142-6.
     
174. Radecki Breitkopf C, Ridgeway JL, Asiedu GB, Carroll K, Tenney M, Jatoi A. Ovarian cancer patients' and their family members' perspectives on novel vaccine and virotherapy trials. Clin Trials. 2016 Dec; 13 (6):660-664 Epub 2016 June 27
     View PubMed
175. Hofheinz RD, Deplanque G, Komatsu Y, Kobayashi Y, Ocvirk J, Racca P, Guenther S, Zhang J, Lacouture ME, Jatoi A. Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors. Oncologist. 2016 Dec; 21 (12):1483-1491 Epub 2016 July 22
     View PubMed
176. Egloff H, Jatoi A. Do Ovarian Cancer Patients with a Family History of Cancer (Suspected BRCA1 or BRCA2 Mutation) Suffer Greater Chemotherapy Toxicity? Cancer Invest. 2016 Nov 25; 34: (10)531-535.
     View PubMed
177. Lerner L, Gyuris J, Nicoletti R, Gifford J, Krieger B, Jatoi A. Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss. Oncol Lett. 2016 Nov; 12 (5):4219-4223 Epub 2016 Sept 23
     View PubMed
178. Kuhle CL, Kapoor E, Sood R, Thielen JM, Jatoi A, Faubion SS. Menopausal hormone therapy in cancer survivors: A narrative review of the literature. Maturitas. 2016 Oct; 92:86-96 Epub 2016 July 27
     View PubMed
179. Ho TP, Foster NR, Jatoi A. A Single-Institution Study of Demographics and Outcomes of Adult Patients With Multiple Cancers. Cancer Control. 2016 Oct; 23: (4)455-460.
     View PubMed
180. Jatoi A, Qin R, Satele D, Dakhil S, Kumar P, Johnson DB, Thomas SP, Stella PJ, Castillo J, Li M, Fernandez-Zapico M. "Enjoy glass of wine before eating:" a randomized trial to test the orexigenic effects of this advice in advanced cancer patients. Support Care Cancer. 2016 Sep; 24 (9):3739-46 Epub 2016 Apr 02
     View PubMed
181. Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Doherty JP, Giri N, Nadanaciva S, O'Connell J, Sbar E, Piperdi B, Garon EB. A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer. Ann Oncol. 2016 Sep; 27 (9):1712-8 Epub 2016 June 10
     View PubMed
182. Sood R, Novotny P, Faubion SS, Thielen JM, Shuster LT, Kuhle CL, Kapoor E, Marnach M, Barrette B, Jatoi A. Self-reported verbal abuse in 1300+ older women within a private, tertiary women's health clinic. Arch Gerontol Geriatr. 2016 Sep-Oct; 66:62-5 Epub 2016 May 12
     View PubMed
183. Roter DL, Yost KJ, O'Byrne T, Branda M, Leppin A, Kimball B, Fernandez C, Jatoi A, Kumbamu A, Montori V, Koenig B, Geller G, Larson S, Tilburt J. Communication predictors and consequences of Complementary and Alternative Medicine (CAM) discussions in oncology visits. Patient Educ Couns. 2016 Sep; 99 (9):1519-25 Epub 2016 June 04
     View PubMed
184. Kumar A, Moynagh MR, Multinu F, Cliby WA, McGree ME, Weaver AL, Young PM, Bakkum-Gamez JN, Langstraat CL, Dowdy SC, Jatoi A, Mariani A. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer. Gynecol Oncol. 2016 Aug; 142 (2):311-6 Epub 2016 June 02
     View PubMed
185. Harris FR, Kovtun IV, Smadbeck J, Multinu F, Jatoi A, Kosari F, Kalli KR, Murphy SJ, Halling GC, Johnson SH, Liu MC, Mariani A, Vasmatzis G. Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers. Sci Rep. 2016 Jul 20; 6:29831 Epub 2016 July 20
     View PubMed
186. Kilari D, Soto-Perez-de-Celis E, Mohile SG, Alibhai SM, Presley CJ, Wildes TM, Klepin HD, Demark-Wahnefried W, Jatoi A, Harrison R, Won E, Mustian KM. Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting. J Geriatr Oncol. 2016 Jul; 7 (4):293-304 Epub 2016 May 31
     View PubMed
187. Presley CJ, Dotan E, Soto-Perez-de-Celis E, Jatoi A, Mohile SG, Won E, Alibhai S, Kilari D, Harrison R, Klepin HD, Wildes TM, Mustian K, Demark-Wahnefried W. Gaps in nutritional research among older adults with cancer. J Geriatr Oncol. 2016 Jul; 7 (4):281-92 Epub 2016 July 05
     View PubMed
188. Shin JY, Kizilbash SH, Robinson SI, Uhm JH, Hammack JE, Lachance DH, Buckner JC, Jatoi A. Seizures in patients with primary brain tumors: what is their psychosocial impact? J Neurooncol. 2016 Jun; 128 (2):285-91 Epub 2016 Mar 15
     View PubMed
189. Vegunta S, Kuhle C, Kling JM, Files JA, Kapoor E, David PS, Rullo J, Sood R, Thielen JM, Jatoi A, Schroeder DR, Faubion SS. The association between recent abuse and menopausal symptom bother: results from the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS). Menopause. 2016 May; 23 (5):494-8
     View PubMed
190. Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A. Ureteral obstruction in cancer patients: a qualitative study. Psychooncology. 2016 May; 25 (5):605-9 Epub 2015 June 22
     View PubMed
191. Tran E, Spiceland C, Sandhu NP, Jatoi A. Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer. Am J Hosp Palliat Care. 2016 Apr; 33 (3):272-5 Epub 2014 Dec 31
     View PubMed
192. Jatoi A, Muss H, Allred JB, Cohen HJ, Ballman K, Hopkins JO, Gajra A, Lafky J, Wolff A, Kottschade L, Gralow J, Hurria A. Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301). Psychooncology. 2016 Apr; 25 (4):441-6 Epub 2015 May 20
     View PubMed
193. Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff AC, Gralow J, Morganstern DE, Magrinat G, Cohen HJ, Muss HB. Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907. J Clin Oncol. 2016 Mar 1; 34 (7):699-705 Epub 2016 Jan 11
     View PubMed
194. Jatoi A, Vierkant RA, Hawthorne KM, Block MS, Ramus SJ, Larson NB, Fridley BL, Goode EL. Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer. Oncology. 2016; 90 (2):59-68 Epub 2016 Jan 19
     View PubMed
195. Fearon K, Argiles JM, Baracos VE, Bernabei R, Coats A, Crawford J, Deutz NE, Doehner W, Evans WJ, Ferrucci L, Garcia JM, Gralla RJ, Jatoi A, Kalantar-Zadeh K, Lainscak M, Morley JE, Muscaritoli M, Polkey MI, Rosano G, Rossi-Fanelli F, Schols AM, Strasser F, Vellas B, von Haehling S, Anker SD. Request for regulatory guidance for cancer cachexia intervention trials. J Cachexia Sarcopenia Muscle. 2015 Dec; 6 (4):272-4 Epub 2015 Nov 11
     View PubMed
196. Mehner C, Oberg AL, Kalli KR, Nassar A, Hockla A, Pendlebury D, Cichon MA, Goergen KM, Maurer MJ, Goode EL, Keeney GL, Jatoi A, Sahin-Toth M, Copland JA, Radisky DC, Radisky ES. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers. Oncotarget. 2015 Nov 3; 6 (34):35737-54
     View PubMed
197. Jatoi A, Foster NR, Kalli KR, Vierkant RA, Zhang Z, Larson MC, Fridley B, Goode EL. Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival. BMC Cancer. 2015 Oct 15; 15:711
     View PubMed
198. Menon S, Foster NR, Looker S, Sorgatz K, Kasi PM, McWilliams RR, Jatoi A. Should Vital Signs Be Routinely Obtained Prior to Intravenous Chemotherapy? Results From a 2-Center Study. Cancer Control. 2015 Oct; 22 (4):515-9
     View PubMed
199. Sadak KT, Bahr TL, Moen C, Neglia JP, Jatoi A. The clinical and research infrastructure of a childhood cancer survivor program. J Cancer Educ. 2015 Sep; 30(3):471-6.
     View PubMed
200. Xie D, Marks R, Zhang M, Jiang G, Jatoi A, Garces YI, Mansfield A, Molina J, Yang P. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers. J Thorac Oncol. 2015 Aug; 10 (8):1213-20
     View PubMed
201. Spiceland CM, Olivier KR, Jatoi A. Radiation-Refractory Brain Metastases in Patients with Non-Small Cell Lung Cancer. J Palliat Med. 2015 Aug; 18: (8)707-10.
     View PubMed
202. AlHilli MM, Bakkum-Gamez JN, Mariani A, Weaver AL, McGree ME, Keeney GL, Jatoi A, Dowdy SC, Podratz KC. Risk-adjusted outcomes in elderly endometrial cancer patients: implications of the contrasting impact of age on progression-free and cause-specific survival. Gynecol Oncol. 2015 Jul; 138(1):133-40. Epub 2015 Apr 17.
     View PubMed
203. Hubbard JM, Jatoi A. Incorporating biomarkers of frailty and senescence in cancer therapeutic trials. J Gerontol A Biol Sci Med Sci. 2015 Jun; 70(6):722-8. Epub 2014 Apr 26.
     View PubMed
204. Piderman KM, Breitkopf CR, Jenkins SM, Lovejoy LA, Dulohery YM, Marek DV, Durland HL, Head DL, Swanson SW, Hogg JT, Evans JL, Jorgenson SE, Bunkowski LJ, Jones KL, Euerle TT, Kwete GM, Miller KA, Morris JR, Yoder TJ, Lapid MI, Jatoi A. The feasibility and educational value of Hear My Voice, a chaplain-led spiritual life review process for patients with brain cancers and progressive neurologic conditions. J Cancer Educ. 2015 Jun; 30 (2):209-12
     View PubMed
205. Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, Haddock M, Dowdy S, Jatoi A. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015 May; 23 (5):1303-9 Epub 2014 Oct 23
     View PubMed
206. Del Fabbro E, Jatoi A, Davis M, Fearon K, di Tomasso J, Vigano A. Health professionals' attitudes toward the detection and management of cancer-related anorexia-cachexia syndrome, and a proposal for standardized assessment. J Community Support Oncol. 2015 May; 13(5):181-7.
     View PubMed
207. Piderman KM, Breitkopf CR, Jenkins SM, Euerle TT, Lovejoy LA, Kwete GM, Jatoi A. A Chaplain-led Spiritual Life Review Pilot Study for Patients with Brain Cancers and Other Degenerative Neurologic Diseases. Rambam Maimonides Med J. 2015 Apr; 6 (2):e0015 Epub 2015 Apr 29
     View PubMed
208. Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, Platek ME, Price W, Stewart M, Teknos TN, Moskowitz B. The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer. 2015; 67(2):339-53.
     View PubMed
209. Liu L, Xu H, Wang W, Wu C, Chen Y, Yang J, Cen P, Xu J, Liu C, Long J, Guha S, Fu D, Ni Q, Jatoi A, Chari S, McCleary-Wheeler AL, Fernandez-Zapico ME, Li M, Yu X. A preoperative serum signature of CEA+/CA125+/ CA19-9=1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer. Int J Cancer. 2015; 136(9):2216-27.
     View PubMed
210. Jatoi A, Radecki Breitkopf C, Foster NR, Block MS, Grudem M, Wahner Hendrickson A, Carlson RE, Barrette B, Karlin N, Fields AP. A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients. Oncology. 2015; 88 (4):208-13 Epub 2014 Dec 06
     View PubMed
211. Shinde S, Wanger T, Novotny P, Grudem M, Jatoi A. Disease-free ovarian cancer patients report severe pain and fatigue over time: prospective quality of life assessment in a consecutive series. Eur J Gynaecol Oncol. 2015; 36(2):155-60.
     View PubMed
212. Aapro M, Arends J, Bozzetti F, Fearon K, Grunberg SM, Herrstedt J, Hopkinson J, Jacquelin-Ravel N, Jatoi A, Kaasa S, Strasser F, ESMO (European School of Medical Oncology). Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol. 2014 Aug; 25 (8):1492-9 Epub 2014 Feb 25
     View PubMed
213. Gajra A, Jatoi A. Non-Small-Cell Lung Cancer in Elderly Patients: A Discussion of Treatment Options. J Clin Oncol. 2014 Jul 28. [Epub ahead of print]
     View PubMed
214. Breitkopf CR, Stephens EK, Jatoi A. Hospice in end-of-life patients with cancer: does it lead to changes in nonhospice health care utilization after stopping cancer treatment? Am J Hosp Palliat Care. 2014 Jun; 31 (4):392-5 Epub 2013 May 10
     View PubMed
215. Wanger T, Foster NR, Nguyen PL, Jatoi A. Patients' rationale for declining participation in a cancer-associated weight loss study. J Cachexia Sarcopenia Muscle. 2014 Jun; 5 (2):121-5 Epub 2014 Mar 13
     View PubMed
216. Egloff H, Jatoi A. Pemetrexed for ovarian cancer: a systematic review of the published literature and a consecutive series of patients treated in a nonclinical trial setting. Case Rep Oncol. 2014 May; 7 (2):541-9 Epub 2014 July 30
     View PubMed
217. Kenderian S, Stephens EK, Jatoi A. Ostomies in rectal cancer patients: what is their psychosocial impact? Eur J Cancer Care (Engl). 2014 May; 23 (3):328-32 Epub 2013 Oct 10
     View PubMed
218. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Martin JR, Keeney GL, Jatoi A, Gostout BS, Podratz KC. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy. Gynecol Oncol. 2014 Mar; 132(3):578-84. Epub 2014 Jan 14.
     View PubMed
219. Hayman SR, Calle JC, Jatoi A, Craici IM, Wagner SJ, Weaver AL, Greene EL, Grande JP, Garovic VD. Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignancies. Oncology. 2014; 86 (5-6):271-8 Epub 2014 June 04
     View PubMed
220. Patel K, Stephens EK, Miller RC, Jatoi A. Incidence and outcomes of chemotherapy and radiation in morbidly obese patients with locally advanced lung and esophageal cancers: a single-institution experience. Cancer Control. 2014 Jan; 21 (1):63-6
     View PubMed
221. Menon SP, Jatoi A. Non-small-cell lung cancer in the elderly with an emphasis on chemotherapy in the adjuvant and metastatic disease settings Lung Cancer Management. 2014; 3 (5):411-6
     
222. Jackson AE, Stephens EK, Jatoi A. Causes and palliation of transfusion-associated vaginal bleeding in patients with metastatic cancer. Int J Gynecol Cancer. 2014 Jan; 24 (1):172-5
     View PubMed
223. Patel K, Foster NR, Farrell A, Le-Lindqwister NA, Mathew J, Costello B, Reynolds J, Meyers JP, Jatoi A. Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature. J Cancer Educ. 2013 Dec; 28 (4):770-6
     View PubMed
224. Mansfield AS, Fields AP, Jatoi A, Qi Y, Adjei AA, Erlichman C, Molina JR. Phase I dose escalation study of the PKCiota inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. Anticancer Drugs. 2013 Nov; 24 (10):1079-83
     View PubMed
225. Kimball BC, James KM, Yost KJ, Fernandez CA, Kumbamu A, Leppin AL, Robinson ME, Geller G, Roter DL, Larson SM, Lenz HJ, Garcia AA, Braddock CH, Jatoi A, de Nuncio ML, Montori VM, Koenig BA, Tilburt JC. Listening in on difficult conversations: an observational, multi-center investigation of real-time conversations in medical oncology. BMC Cancer. 2013 Oct 04; 13:455.
     View PubMed
226. Lim MY, Stephens EK, Novotny P, Price K, Salayi M, Roeker L, Peethambaram P, Jatoi A. Self-perceptions of age among 292 chemotherapy-treated cancer patients: Exploring associations with symptoms and survival. J Geriatr Oncol. 2013 Jul; 4(3):249-54.
     View PubMed
227. Torres ML, Hartmann LC, Cliby WA, Kalli KR, Young PM, Weaver AL, Langstraat CL, Jatoi A, Kumar S, Mariani A. Nutritional status, CT body composition measures and survival in ovarian cancer. Gynecol Oncol. 2013 Jun; 129 (3):548-53 Epub 2013 Mar 21
     View PubMed
228. Mansfield AS, Jatoi A. Asphyxiation with a fentanyl patch. Case Rep Oncol. 2013 May; 6 (2):242-4 Epub 2013 May 01
     View PubMed
229. Griffin BR, Stephens EK, Jatoi A. Are 5-7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed? Observations from a Case Series. Case Rep Oncol. 2013 May; 6 (2):339-42 Epub 2013 June 26
     View PubMed
230. Feely MA, Collins CS, Daniels PR, Kebede EB, Jatoi A, Mauck KF. Preoperative testing before noncardiac surgery: guidelines and recommendations. Am Fam Physician. 2013 Mar 15; 87 (6):414-8
     View PubMed
231. Stauder MC, Romero Y, Kabat B, Atherton PJ, Geno D, Deschamps C, Jatoi A, Sloan JA, Botros M, Jung KW, Arora AS, Miller RC, EABE Registry Consortium. Overall survival and self-reported fatigue in patients with esophageal cancer. Support Care Cancer. 2013 Feb; 21 (2):511-9 Epub 2012 July 29
     View PubMed
232. Garcia JM, Jatoi A, Del Fabbro E. The potential of ghrelin in cancer anorexia-cachexia. European Oncology and Haematology. 2013; 9(2):77-83.
     
233. Jatoi A, Allred JB, Suman VJ, Creagan ET, Croghan GA, Amatruda T, Markovic SN. Is Age >/= 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials. J Geriatr Oncol. 2012 Oct 1; 3 (4):307-311 Epub 2012 May 07
     View PubMed
234. Ramiscal JA, Jatoi A. Nasal septal perforation from bevacizumab: a discussion of outcomes, management, and pharmacovigilance. Curr Oncol Rep. 2012 Aug; 14 (4):307-10
     View PubMed
235. Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer. 2012 Aug; 20(8):1729-35. Epub 2011 Sep 16.
     View PubMed
236. Chen J, Qi Y, Wampfler JA, Jatoi A, Garces YI, Busta AJ, Mandrekar SJ, Yang P. Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer. 2012 Jul; 48(11):1593-601. Epub 2012 Jan 12.
     View PubMed
237. Jatoi A. Adjuvant chemotherapy and targeted therapy in elderly non-small-cell lung cancer patients. Aging health. 2012 Jun 1; 8 (3):309-316
     View PubMed
238. Poterucha T, Burnette B, Jatoi A. A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab. Med Oncol. 2012 Jun; 29 (2):1005-9 Epub 2011 Mar 12
     View PubMed
239. Varkey P, Jatoi A, Williams A, Mayer A, Ko M, Files J, Blair J, Hayes S. The positive impact of a facilitated peer mentoring program on academic skills of women faculty. BMC Med Educ. 2012 Mar 23; 12:14
     View PubMed
240. Breitkopf CR, Egginton JS, Naessens JM, Montori VM, Jatoi A. Who is counseled to lose weight? Survey results and anthropometric data from 3,149 lower socioeconomic women. J Community Health. 2012 Feb; 37 (1):202-7
     View PubMed
241. Jatoi A, Nieva JJ, Qin R, Loprinzi CL, Wos EJ, Novotny PJ, Moore DF Jr, Mowat RB, Bechar N, Pajon ER Jr, Hartmann LC. A pilot study of long-acting octreotide for symptomatic malignant ascites. Oncology. 2012; 82 (6):315-20 Epub 2012 May 10
     View PubMed
242. Yang P, Cheville AL, Wampfler JA, Garces YI, Jatoi A, Clark MM, Cassivi SD, Midthun DE, Marks RS, Aubry MC, Okuno SH, Williams BA, Nichols FC, Trastek VF, Sugimura H, Sarna L, Allen MS, Deschamps C, Sloan JA. Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol. 2012 Jan; 7 (1):64-70
     View PubMed
243. Yang P, Kulig K, Boland JM, Erickson-Johnson MR, Oliveira AM, Wampfler J, Jatoi A, Deschamps C, Marks R, Fortner C, Stoddard S, Nichols F, Molina J, Aubry MC, Tang H, Yi ES. Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma. J Thorac Oncol. 2012 Jan; 7 (1):90-7
     View PubMed
244. Stephens EK, Nguyen PL, Radecki Breitkopf C, Jatoi A. Former military officers from the Republic of Vietnam now living in the united states (US): exploring their perceptions of the US healthcare system. J Community Health. 2011 Dec; 36 (6):992-8
     View PubMed
245. Jatoi A, Qi Y, Wampfler JA, Busta AJ, Yang P, Mandrekar S. The purported effects of alcohol on appetite and weight in lung cancer patients. Nutr Cancer. 2011 Nov; 63 (8):1251-5 Epub 2011 Oct 14
     View PubMed
246. Coleman S, Kovtun I, Nguyen PL, Pittelkow M, Jatoi A. A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors. Psychooncology. 2011 Nov; 20 (11):1246-9 Epub 2010 Sept 23
     View PubMed
247. Jatoi A, Dakhil SR, Sloan JA, Kugler JW, Rowland KM Jr, Schaefer PL, Novotny PJ, Wender DB, Gross HM, Loprinzi CL, North Central Cancer Treatment Group. Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB). Support Care Cancer. 2011 Oct; 19 (10):1601-7 Epub 2010 Sept 06
     View PubMed
248. Coleman S, Peethambaram PP, Jatoi A. Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment. J Cancer Educ. 2011 Sep; 26 (3):474-7
     View PubMed
249. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J Pain Symptom Manage. 2011 Aug; 42 (2):213-21 Epub 2011 Mar 12
     View PubMed
250. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. J Pain Symptom Manage. 2011 Aug; 42 (2):202-12 Epub 2011 Mar 12
     View PubMed
251. Kovtun IV, Harris KJ, Jatoi A, Jevremovic D. Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice. Carcinogenesis. 2011 Jul; 32 (7):1085-92 Epub 2011 May 05
     View PubMed
252. Jatoi A, Breitkopf CR. Is Spanish language a barrier to domestic violence assessment? J Womens Health (Larchmt). 2011 Jul; 20 (7):1111-6 Epub 2011 June 01
     View PubMed
253. Mitchell J, Jatoi A. Parenteral nutrition in patients with advanced cancer: merging perspectives from the patient and healthcare provider. Semin Oncol. 2011 Jun; 38 (3):439-42
     View PubMed
254. Stephens EK, Nguyen PL, Jatoi A. Practical strategies to circumvent and/or surmount six barriers in health disparities research: observations from a pilot project among Vietnamese Americans. J Cancer Educ. 2011 Jun; 26 (2):243-7
     View PubMed
255. Mc Kean H, Stella PJ, Hillman SL, Rowland KM, Cannon MW, Behrens RJ, Gross GG, Sborov MD, Friedman EL, Jatoi A. Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222. Cancer Invest. 2011 May; 29 (4):266-71 Epub 2011 Feb 23
     View PubMed
256. Ramiscal JA, Jatoi A. Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients. Acta Oncol. 2011 May; 50 (4):578-81 Epub 2010 Nov 26
     View PubMed
257. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May; 12(5):489-95. Epub 2011 Feb 04.
     View PubMed
258. Sood R, Shuster L, Smith R, Vincent A, Jatoi A. Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians. J Am Board Fam Med. 2011 Mar-Apr; 24 (2):202-10
     View PubMed
259. Solomon BM, Jatoi A. Epidermal growth factor receptor (EGFR) inhibitor-induced rash: a consecutive patient series that illustrates the need for rigorous palliative trials. J Palliat Med. 2011 Feb; 14 (2):153-6 Epub 2011 Jan 12
     View PubMed
260. Sood R, Jatoi A. Integrative nutritional approaches to loss of weight and appetite in patients with advanced cancer. European Journal of Integrative Medicine. 2011; 3(3):e233-6.
     
261. Jatoi A. Integrative and complementary medicine among cancer patients: At what price? European Journal of Integrative Medicine. 2011; 3(3):e139-41.
     
262. Vaidya R, Sood R, Karlin N, Jatoi A. Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Oncology. 2011; 81 (1):9-11 Epub 2011 Sept 02
     View PubMed
263. Aldairy Y, Nguyen PL, Jatoi A. Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting? Eur J Cancer Care (Engl). 2011 Jan; 20 (1):72-6
     View PubMed
264. Mateen FJ, Nassar A, Bardia A, Jatoi A, Haddock MG, Buckner JC, Lachance DH. Spinal intradural extraosseous Ewing's sarcoma. Rare Tumors. 2011; 3(1):e7. Epub 2011 Mar 30.
     View PubMed
265. Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med. 2011; 62:265-79.
     View PubMed
266. Tan TS, Jatoi A. End-of-life hospital costs in cancer patients: do advance directives or routes of hospital admission make a difference? Oncology. 2011; 80 (1-2):118-22 Epub 2011 June 14
     View PubMed
267. Butts M, Jatoi A. A systematic compilation of reports published on opioid-related problems. J Opioid Manag. 2011 Jan-Feb; 7 (1):35-45
     View PubMed
268. Vincent A, Whipple MO, Luedtke CA, Oh TH, Sood R, Smith RL, Jatoi A. Pain and other symptom severity in women with fibromyalgia and a previous hysterectomy. J Pain Res. 2011; 4:325-9 Epub 2011 Oct 07
     View PubMed
269. Burnette B, Jatoi A. Parenteral nutrition in patients with cancer: recent guidelines and a need for further study. Curr Opin Support Palliat Care. 2010 Dec; 4(4):272-5.
     View PubMed
270. Jatoi A, Soori G, Foster NR, Hiatt BK, Knost JA, Fitch TR, Callister MD, Nichols FC 3rd, Husted TM, Alberts SR. Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors. J Thorac Oncol. 2010 Dec; 5 (12):1994-8
     View PubMed
271. Miller RC, Atherton PJ, Kabat BF, Fredericksen MB, Geno DM, Deschamps C, Jatoi A, Sloan JA, Romero Y. Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study. Dig Dis Sci. 2010 Oct; 55 (10):2860-8 Epub 2010 Jan 22
     View PubMed
272. Jatoi A, Qi Y, Kendall G, Jiang R, McNallan S, Cunningham J, Mandrekar S, Yang P. The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Support Care Cancer. 2010 Oct; 18 (10):1299-304 Epub 2009 Dec 15
     View PubMed
273. Jatoi A, Schild SE, Foster N, Henning GT, Dornfeld KJ, Flynn PJ, Fitch TR, Dakhil SR, Rowland KM, Stella PJ, Soori GS, Adjei AA. A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422). Ann Oncol. 2010 Oct; 21 (10):2040-2044 Epub 2010 June 21
     View PubMed
274. Larson BR, Looker S, Herrera DM, Creagan ET, Hayman SR, Kaur JS, Jatoi A. Cancer patients and their companion animals: results from a 309-patient survey on pet-related concerns and anxieties during chemotherapy. J Cancer Educ. 2010 Sep; 25 (3):396-400 Epub 2010 Feb 24
     View PubMed
275. Halfdanarson TR, Jatoi A. Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Curr Oncol Rep. 2010 Jul; 12(4):247-52.
     View PubMed
276. Jatoi A, Smith EL, Gunderson HD, Hartgers ML, Looker SA, Santana-Davila R, McWilliams RR. Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy. J Oncol Pract. 2010 Jul; 6 (4):210-2 Epub 2010 June 22
     View PubMed
277. Behl D, Jatoi A. What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey. J Palliat Med. 2010 Jul; 13 (7):831-5
     View PubMed
278. Jatoi A, Ritter HL, Dueck A, Nguyen PL, Nikcevich DA, Luyun RF, Mattar BI, Loprinzi CL. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer. 2010 May; 68 (2):234-9 Epub 2009 Aug 08
     View PubMed
279. Jatoi A. Cancer chemotherapy: with or without food? Support Care Cancer. 2010 May; 18 Suppl 2:S13-6 Epub 2009 June 01
     View PubMed
280. Hartgers M, Jatoi A. E-mail and photographs: a case report of a patient-initiated diagnostic tool in the era of electronic communication. J Palliat Med. 2010 Mar; 13 (3):335-7
     View PubMed
281. Jatoi A, Foster NR, Egner JR, Burch PA, Stella PJ, Rubin J, Dakhil SR, Sargent DJ, Murphy BR, Alberts SR. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials. Int J Oncol. 2010 Mar; 36 (3):601-6
     View PubMed
282. Chen J, Jiang R, Garces YI, Jatoi A, Stoddard SM, Sun Z, Marks RS, Liu Y, Yang P. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer. 2010 Feb; 67 (2):221-6 Epub 2009 June 03
     View PubMed
283. Jatoi A, Thrower A, Sloan JA, Flynn PJ, Wentworth-Hartung NL, Dakhil SR, Mattar BI, Nikcevich DA, Novotny P, Sekulic A, Loprinzi CL. Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4). Oncologist. 2010; 15 (9):1016-22 Epub 2010 Aug 26
     View PubMed
284. Wood LS, Lemont H, Jatoi A, Lacouture ME, Robert C, Keating K, Anderson R. Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors. Community Oncol. 2010; 7(1):23-9.
     
285. Jatoi A, Hillman SL, Ziegler KL, Stella PJ, Soori GS, Rowland KM. Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222. Cancer Manag Res. 2009 Jun 17; 1:61-8 Epub 2009 June 17
     View PubMed
286. Huang J, Jatoi A. Morbidity and mortality in patients with cancer who become nonambulatory after spinal cord compression: a case series on end-of-life care. J Palliat Med. 2009 Mar; 12 (3):219-22
     View PubMed
287. Anderson R, Jatoi A, Robert C, Wood LS, Keating KN, Lacouture ME. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs). Oncologist. 2009 Mar; 14(3):291-302. Epub 2009 Mar 10.
     View PubMed
288. Donahue JM, Nichols FC, Li Z, Schomas DA, Allen MS, Cassivi SD, Jatoi A, Miller RC, Wigle DA, Shen KR, Deschamps C. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009 Feb; 87 (2):392-8; discussion 398-9
     View PubMed
289. Tan TS, Walia T, Galanis E, Goetz MP, Rubin J, Jatoi A. If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology trainees. J Cancer Educ. 2009; 24 (3):200-3
     View PubMed
290. Jacobs NL, Que FG, Miller RC, Vege SS, Farnell MB, Jatoi A. Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer. J Gastrointest Cancer. 2009; 40 (1-2):46-50
     View PubMed
291. Jatoi A, Green EM, Rowland KM Jr, Sargent DJ, Alberts SR. Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147. Oncology. 2009; 77 (2):120-3 Epub 2009 July 22
     View PubMed
292. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD. Cachexia: a new definition. Clin Nutr. 2008 Dec; 27(6):793-9. Epub 2008 Aug 21
     View PubMed
293. Jatoi A, Nguyen PL. Side effects and pharmaceutical company bias: adverse event reporting in cancer supportive and palliative care trials. Expert Opin Investig Drugs. 2008 Dec; 17 (12):1787-90
     View PubMed
294. Walia T, Quevedo JF, Hobday TJ, Croghan G, Jatoi A. Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy. Ther Clin Risk Manag. 2008 Dec; 4(6):1363-6.
     View PubMed
295. Jatoi A, Nguyen PL. Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy. Oncologist. 2008 Nov; 13 (11):1201-4 Epub 2008 Nov 06
     View PubMed
296. Jatoi A, Rowland K, Sloan JA, Gross HM, Fishkin PA, Kahanic SP, Novotny PJ, Schaefer PL, Johnson DB, Tschetter LK, Loprinzi CL. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer. 2008 Aug 15; 113 (4):847-53
     View PubMed
297. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol. 2008 Jul 20; 26 (21):3511-6
     View PubMed
298. Clark MM, Novotny PJ, Patten CA, Rausch SM, Garces YI, Jatoi A, Sloan JA, Yang P. Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer. 2008 Jul; 61 (1):117-22 Epub 2008 Feb 19
     View PubMed
299. Mateen FJ, Jatoi A, Lineberry TW, Aranguren D, Creagan ET, Croghan GA, Jett JR, Marks RS, Molina JR, Richardson RL. Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology. 2008 Jul; 17 (7):721-5
     View PubMed
300. Solomon BM, Jatoi A. Rash from EGFR inhibitors: opportunities and challenges for palliation. Curr Oncol Rep. 2008 Jul; 10 (4):304-8
     View PubMed
301. Halfdanarson TR, Thordardottir E, West CP, Jatoi A. Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol. 2008 May-Jun; 6(5):234-7.
     View PubMed
302. Galanis E, Carlson SK, Foster NR, Lowe V, Quevedo F, McWilliams RR, Grothey A, Jatoi A, Alberts SR, Rubin J. Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. Mol Ther. 2008 May; 16 (5):979-84 Epub 2008 Mar 18
     View PubMed
303. McKean H, Looker S, Hartmann LC, Hayman SR, Kaur JS, McWilliams RR, Peethambaram PP, Stahl JF, Jatoi A. Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions. J Nutr Educ Behav. 2008 May-Jun; 40: (3)144-8.
     View PubMed
304. Jatoi A, Dakhil SR, Foster NR, Ma C, Rowland KM Jr, Moore DF Jr, Jaslowski AJ, Thomas SP, Hauge MD, Flynn PJ, Stella PJ, Alberts SR. Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). J Thorac Oncol. 2008 May; 3 (5):516-20
     View PubMed
305. Jatoi A. Weight loss in patients with advanced cancer: effects, causes, and potential management. Curr Opin Support Palliat Care. 2008 Mar; 2(1):45-8.
     View PubMed
306. Katipamula R, Jatoi A, Foster NR, Nichols F, Rubin J, Callister M, Gunderson L, Alberts S. Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E. Clin Med Oncol. 2008; 2:223-5 Epub 2008 Apr 01
     View PubMed
307. Tan TS, Jatoi A. An update on advance directives in the medical record: findings from 1186 consecutive patients with unresectable exocrine pancreas cancer. J Gastrointest Cancer. 2008; 39 (1-4):100-3 Epub 2009 Jan 06
     View PubMed
308. Singh PP, Jatoi A. Do gender-based disparities in authorship also exist in cancer palliative care? A 15-year survey of the cancer palliative care literature. J Cancer Educ. 2008; 23(3):192-4.
     View PubMed
309. Kovtun IV, Engh J, Jatoi A. A survey of patient advocates within the National Cancer Institute's Prostate Cancer SPORE Program: who are they? what motivates them? what might they tell us? J Cancer Educ. 2008; 23 (4):222-5
     View PubMed
310. Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, Sloan J, Yang P. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort. Oncologist. 2007 Dec; 12 (12):1456-63
     View PubMed
311. Jatoi A, Martenson JA, Foster NR, McLeod HL, Lair BS, Nichols F, Tschetter LK, Moore DF Jr, Fitch TR, Alberts SR, North Central Cancer Treatment Group (N0044). Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Am J Clin Oncol. 2007 Oct; 30(5):507-13.
     View PubMed
312. Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer. 2007 Sep 15; 110 (6):1396-403
     View PubMed
313. Alsawaf MA, Jatoi A. Shopping for nutrition-based complementary and alternative medicine on the Internet: how much money might cancer patients be spending online? J Cancer Educ. 2007 Fall; 22(3):174-6.
     View PubMed
314. Jatoi A. Sunshine and rash: testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash. Support Cancer Ther. 2007 Sep 1; 4 (4):198-202
     View PubMed
315. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA, North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic. The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer. 2007 Jul 15; 110(2):363-8.
     View PubMed
316. Behl D, Jatoi A. Pharmacological options for advanced cancer patients with loss of appetite and weight. Expert Opin Pharmacother. 2007 Jun; 8 (8):1085-90
     View PubMed
317. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. Mayo Clin Proc. 2007 Jun; 82(6):751-70.
     View PubMed
318. Ma C, Jatoi A. Wine for appetite loss: "how do you know?". J Clin Oncol. 2007 Apr 1; 25(10):1285-7.
     View PubMed
319. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67 (5):1318-22
     View PubMed
320. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol. 2007 Mar; 5(3):119-25, 128.
     View PubMed
321. Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, Tan W, North Central Cancer Treatment Group. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology. 2007 Feb; 69 (2):289-94
     View PubMed
322. Ma C, Mandrekar SJ, Alberts SR, Croghan GA, Jatoi A, Reid JM, Hanson LJ, Bruzek L, Tan AD, Pitot HC, Erlichman C, Wright JJ, Adjei AA. A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies. Cancer Chemother Pharmacol. 2007 Feb; 59(2):207-15. Epub 2006 Jun 09.
     View PubMed
323. Halfdanarson TR, Jatoi A. Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trial. Support Cancer Ther. 2007 Jan 1; 4 (2):119-22
     View PubMed
324. Jatoi A. Sunshine and rash: Testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash. Supportive Cancer Ther. 2007; 4(4):198-202.
     
325. Jatoi A, Dakhil S, Foster N, Ma C, Rowland K, Moore D, Jaslowksi A, Thomas S, Hauge M, Flynn P, Stella P, Alberts S. Bortezobim, Paclitaxel, and Carboplatin as a First-Line Regimen for Patients With Metastatic Esophageal Cancer: Phase II Results from the NCCTG (N044B). J Thorac Oncol. 2007; 3(5):516-20.
     
326. McKean H, Miller RC, Jatoi A. Non-traumatic vertebral fractures in patients with locally advanced esophageal cancer: a previously unreported, unrecognized problem. Dis Esophagus. 2007; 20: (2)102-6.
     View PubMed
327. Jatoi A, Nguyen PL, Foster N, Sun D, Stella PJ, Campbell M, Tschetter LK, Dakhil SR, Mailliard JA, Nikcevich DA. Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. J Support Oncol. 2007 Jan; 5(1):41-6.
     View PubMed
328. Jatoi A, Aranguren D. A critical look at the role of chemotherapy in older patients with non-small cell lung cancer. J Thorac Oncol. 2007 Jan; 2(1):83-90.
     View PubMed
329. Jatoi A. Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach. J Support Oncol. 2006 Nov-Dec; 4 (10):499-502
     View PubMed
330. Jatoi A, Burch P, Hillman D, Vanyo J, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn P, Young C, Tan W. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a phase II study from the North Central Cancer Treatment Group. J Urol. 2006 Oct 19; 69(2):289-294.
     
331. Mateen F, Jatoi A. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clin Nutr. 2006 Oct; 25(5):711-5. Epub 2006 Jul 25.
     View PubMed
332. Jatoi A, Jacobs JA, Zimmermann E, Johnson ME, Nguyen PL, Hartmann LC. Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across Minnesota. Minn Med. 2006 Oct; 89(10):42-4.
     View PubMed
333. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol. 2006 Fall; 4 (4):143-52
     View PubMed
334. Patiyil S, Chan SN, Jatoi A. New agents, new rashes: an update on skin complications from cancer chemotherapy. Curr Oncol Rep. 2006 Jul; 8 (4):269-74
     View PubMed
335. Chan SN, Okuno SH, Jatoi A. Causes and outcomes of spontaneous pneumothoraces in solid tumor cancer patients: an update for the medical oncologist. J Thorac Oncol. 2006 May; 1 (4):335-8
     View PubMed
336. Giordano KF, Jatoi A, Stella PJ, Foster N, Tschetter LK, Alberts SR, Dakhil SR, Mailliard JA, Flynn PJ, Nikcevich DA, North Central Cancer Treatment Group. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. Ann Oncol. 2006 Apr; 17 (4):652-6 Epub 2006 Feb 23
     View PubMed
337. Jatoi A, Murphy BR, Foster NR, Nikcevich DA, Alberts SR, Knost JA, Fitch TR, Rowland KM Jr, North Central Cancer Treatment Group. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. Ann Oncol. 2006 Jan; 17 (1):29-34 Epub 2005 Nov 22
     View PubMed
338. McKian KP, Miller RC, Cassivi SD, Jatoi A. Curing patients with locally advanced esophageal cancer: an update on multimodality therapy. Dis Esophagus. 2006; 19: (6)448-53.
     View PubMed
339. Jatoi A, Foster N, Wieland B, Murphy B, Nikcevich D, LaPlant B, Palcic MM, Baracos V. The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer. Dis Esophagus. 2006; 19: (4)241-7.
     View PubMed
340. Jatoi A, Hillman S, Stella P, Green E, Adjei A, Nair S, Perez E, Amin B, Schild SE, Castillo R, Jett JR, North Central Cancer Treatment Group. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol. 2005 Dec 20; 23(36):9113-9.
     View PubMed
341. Jatoi A, Giordano KF, Nguyen PL, Sloan J, Hartmann LC. Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group. Support Cancer Ther. 2005 Oct 1; 3 (1):59-62
     View PubMed
342. Jatoi A. Omega-3 fatty acid supplements for cancer-associated weight loss. Nutr Clin Pract. 2005 Aug; 20 (4):394-9
     View PubMed
343. Giordano KF, Jatoi A, Adjei AA, Creagan ET, Croghan G, Frytak S, Jett JR, Marks R, Molina J, Okuno S, Richardson RL. Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution. Lung Cancer. 2005 Aug; 49(2):209-15. Epub 2005 Apr 13.
     View PubMed
344. Giordano KF, Jatoi A. The cancer anorexia/weight loss syndrome: therapeutic challenges. Curr Oncol Rep. 2005 Jul; 7 (4):271-6
     View PubMed
345. Jatoi A. Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome? Crit Rev Oncol Hematol. 2005 Jul; 55(1):37-43.
     View PubMed
346. Jatoi A, Williams B, Nichols F, Marks R, Aubry MC, Wampfler J, Finke EE, Yang P. Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort. Lung Cancer. 2005 Jul; 49(1):77-84. Epub 2005 Apr 18.
     View PubMed
347. Schild SE, Stella PJ, Brooks BJ, Mandrekar S, Bonner JA, McGinnis WL, Mailliard JA, Krook JE, Deming RL, Adjei AA, Jatoi A, Jett JR. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer. 2005 Jun 1; 103(11):2349-54.
     View PubMed
348. Jatoi A, Alberts SR, Foster N, Morton R, Burch P, Block M, Nguyen PL, Kugler J, North Central Cancer Treatment Group. Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group. Support Care Cancer. 2005 Jun; 13 (6):381-6 Epub 2005 Mar 10
     View PubMed
349. Joque L, Jatoi A. Total parenteral nutrition in cancer patients: why and when? Nutrition in Clinical Care. 2005 Apr-Jun; 8(2):89-92.
     View PubMed
350. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's is 20-year experience. Cancer. 2005 Feb 15; 103(4):863-8.
     View PubMed
351. Jatoi A, Williams BA, Marks R, Nichols FC, Aubry MC, Wampfler J, Yang P. Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: results from the Mayo Clinic lung cancer cohort. Nutr Cancer. 2005; 51(1):7-12.
     View PubMed
352. Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, Petersen RC. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Support Care Cancer. 2005 Jan; 13 (1):66-9 Epub 2004 Oct 09
     View PubMed
353. Jatoi A, Jett JR, Sloan J, Novotny P, Ford J, Prabhakar U, Loprinzi CL. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer. 2004 Dec; 12 (12):859-63 Epub 2004 Sept 15
     View PubMed
354. Jatoi A, Martenson J, Mahoney MR, Lair BS, Brindle JS, Nichols F, Caron N, Nichols F, Rowland K, Tschetter L, Alberts S. Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group. Int Semin Surg Oncol. 2004 Nov 8; 1 (1):9 Epub 2004 Nov 08
     View PubMed
355. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, Mailliard JA, Klee GG, Krook JE. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer. 2004 Sep; 12 (9):640-4
     View PubMed
356. Jatoi A, Sideras K, Nguyen PL. Tumor Necrosis Factor-alpha as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome. Support Cancer Ther. 2004 Jul 1; 1 (4):237-42
     View PubMed
357. Jatoi A, Podratz KC, Gill P, Hartmann LC. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. J Support Oncol. 2004 Jul-Aug; 2(4):323-34; discussion 334-7.
     View PubMed
358. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B, North Central Cancer Treatment Group. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004 Jun 15; 22 (12):2469-76
     View PubMed
359. Young CY, Jatoi A, Ward JF, Blute ML. The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer. Curr Med Chem. 2004 Apr; 11 (7):909-23
     View PubMed
360. Kanard A, Frytak S, Jatoi A. Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management. J Support Oncol. 2004 Mar-Apr; 2(2):127-32; discussion 133-5, 138-40.
     View PubMed
361. Kanard A, Jatoi A, Castillo R, Geyer S, Schulz TK, Fitch TR, Rowland KM, Nair S, Krook JE, Kugler JW. Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity. Lung Cancer. 2004 Mar; 43 (3):345-53
     View PubMed
362. de Andrade M, Ebbert JO, Wampfler JA, Miller DL, Marks RS, Croghan GA, Jatoi A, Finke EE, Sellers TA, Yang P. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer. 2004 Feb; 43 (2):127-34
     View PubMed
363. Jatoi A, Nguyen PL. Weight loss in lung cancer patients with refractory, metastatic disease: clinical implications and therapeutic strategies. Oncology Nutrition Connection. 2004 Spr; 12(2):1, 3-5.
     
364. Jatoi A, Foster N, Johnson P, Klee G, Quevedo J, Morton R, Nair S, Kardinal C, Mailliard J. Investigating Four "Myths" Surrounding this symptom in Patients with Metatatic Esophageal Cancer Diseases of the Esophagus. 2004; 17(4):292-6.
     
365. Jatoi A, Ellison N, Burch PA, Quesenberry J, Shogren K, Sloan JA, Young CYF. Prostate cancer patients with maspin-negative tumors can live over a decade. Cancer Therapy. 2004; 2:173-6.
     
366. Jatoi A, Foster N, Johnson P, Klee G, Quevedo JF, Morton RF, Nair S, Kardinal CG, Mailliard JA. Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group. Dis Esophagus. 2004; 17 (4):292-6
     View PubMed
367. Jatoi A. Aggressive multimodality therapy for patients with locally advanced esophageal cancer: is there a role for amifostine? Semin Oncol. 2003 Dec; 30 (6 Suppl 18):72-5
     View PubMed
368. Nguyen PL, Xu Y, Jatoi A. Myelodysplastic syndromes. Am J Clin Pathol. 2003 Dec; 120 Suppl:S25-37.
     View PubMed
369. Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol. 2003 Nov-Dec; 1(4):274-8.
     View PubMed
370. Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study. Am J Clin Oncol. 2003 Oct; 26(5):441-7.
     View PubMed
371. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR, North Central Cancer Treatment Group. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol. 2003 Sep 1; 21 (17):3201-6 Epub 2003 July 21
     View PubMed
372. Jatoi A, Hillman S, Stella PJ, Mailliard JA, Sloan J, Vanone S, Cannon MW, Kutteh L, Kanard A, Jett JR. Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer. 2003 Jul; 11 (7):460-4 Epub 2003 Mar 12
     View PubMed
373. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Res Treat. 2003 Jul; 80(1):99-104.
     View PubMed
374. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol. 2003 May 1; 21(9 Suppl):79s-81s.
     View PubMed
375. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer. 2003 Mar 15; 97 (6):1442-6
     View PubMed
376. Jatoi A. Why should we care about the cancer anorexia/weight loss syndrome? Oncology (Huntington). 2003 Feb; 17: (2 Suppl 2)5-6.
     View PubMed
377. Jatoi A, Loprinzi CL. The cancer anorexia/weight loss syndrome-a review of therapeutic strategies. Business Briefing:European PharmacoTherapy. 2003;102-4.
     
378. Somerfield M, Jatoi A, Nguyen PL, Kumar S, Sloan J, Loprinzi CL. Hazards of quality-of-life data for clinical decision making. J Clin Oncol. 2003; 21(9 suppl):82-3.
     View PubMed
379. Jatoi A, Hillman S, Stella P, Mailliard J, Sloan J, Vanone S, Cannon M, Kutteh L, Kanard A, Jett J. Activities of Daily Living: Exploring their Spectrum and Prognostic Impact in Older, Chemotherapy-Treated Lung Cancer Patients Supportive Care in Cancer. 2003; 7:460-464.
     
380. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol. 2002 Jan 15; 20 (2):567-73
     View PubMed
381. Jatoi A, Yamashita J, Sloan JA, Novotny PJ, Windschitl HE, Loprinzi CL. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer. 2002 Jan; 10 (1):71-5
     View PubMed
382. Jatoi A, Thomas CR Jr. Esophageal cancer and the esophagus: challenges and potential strategies for selective cytoprotection of the tumor-bearing organ during cancer treatment. Semin Radiat Oncol. 2002 Jan; 12 (1 Suppl 1):62-7
     View PubMed
383. Jatoi A, Nguyen PL. Anorexia: Treatment options for patients with advanced cancer. Am J Cancer. 2002; 1(4):269-75.
     
384. Jatoi A, Tirona MT, Cha SS, Alberts SR, Rowland KM, Morton RF, Nair S, Kardinal CG, Stella PJ, Mailliard JA, Sargen D, Goldberg RM. A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia. Int J Gastrointest Cancer. 2002; 32 (2-3):115-23
     View PubMed
385. Jatoi A, Daly BD, Hughes VA, Dallal GE, Kehayias J, Roubenoff R. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure? Ann Thorac Surg. 2001 Aug; 72(2):348-51.
     View PubMed
386. Jatoi A, Daly BD, Kramer G, Mason JB. Folate status among patients with non-small cell lung cancer: a case-control study. J Surg Oncol. 2001 Aug; 77(4):247-52.
     View PubMed
387. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer. 2001 Aug 1; 92 (3):629-33
     View PubMed
388. Jatoi A, Loprinzi CL. An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care. 2001 May; 4 (3):179-82
     View PubMed
389. Jatoi A, Loprinzi CL. Current management of cancer-associated anorexia and weight loss. Oncology (Williston Park). 2001 Apr; 15: (4)497-502, 508; discussion 508-10.
     View PubMed
390. Jatoi A, Cleary MP, Tee CM, Nguyen PL. Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice. Ann Nutr Metab. 2001; 45 (3):116-20
     View PubMed
391. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol. 2000 Aug; 18: (15)2930-2.
     View PubMed
392. Clark JL, Nguyen PL, Jaszcz WB, Jatoi A, Niehans GA. Prognostic variables in male breast cancer. Am Surg. 2000 May; 66(5):502-11.
     View PubMed
393. Jatoi A, Loprinzi CL. Nutritional determinants of survival among patients with breast cancer. Surg Clin North Am. 1999 Oct; 79 (5):1145-56
     View PubMed
394. Jatoi A, Daly BD, Hughes V, Dallal GE, Roubenoff R. The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer. Lung Cancer. 1999 Feb; 23(2):153-8.
     View PubMed
395. Jatoi A, Dallal GE, Nguyen PL. False-negative rates of tumor metastases in the histologic examination of bone marrow. Mod Pathol. 1999 Jan; 12(1):29-32.
     View PubMed
396. Jatoi A, Nguyen PL. Can pathology residents be taught to perform adequate bone marrow biopsies? Acad Med. 1999; 74(4):452.
     View PubMed
397. Jatoi A, Lennon C, O'Brien M, Booth SL, Sadowski J, Mason JB. Protein-calorie malnutrition does not predict subtle vitamin K depletion in hospitalized patients. Eur J Clin Nutr. 1998 Dec; 52(12):934-7.
     View PubMed
398. Jatoi A, Jaromin R, Jennings L, Nguyen PL. Using the absolute neutrophil count as a stand-alone test in a hematology/oncology clinic: an abbreviated test can be preferable. Clin Lab Manage Rev. 1998; 12(4):256-60.
     View PubMed
399. Jatoi A, Garcia-Moliner ML, Daly BD. Parosteal osteosarcoma from a rib. Ann Thorac Surg. 1998; 65(1):265-7.
     View PubMed
400. Camilo ME, Jatoi A, O'Brien M, Davidson K, Sokoll L, Sadowski JA, Mason JB. Bioavailability of phylloquinone from an intravenous lipid emulsion. Am J Clin Nutr. 1998; 67(4):716-21.
     View PubMed
401. Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin intake in post-operative non-small cell lung cancer patients. J Surg Oncol. 1998; 68(4):231-6.
     View PubMed
402. Jatoi A, Hanjosten K, Ross E, Mason JB. A prospective survey for central line skin-site colonization by the pathogen Malassezia furfur among hospitalized adults receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1997 Jul-Aug; 21(4):230-2.
     View PubMed
403. Jatoi A, Jaromin R, Gryzbek D, Nguyen PL. Surveying technologists: a novel method for establishing productivity standards in a clinical hematology laboratory. Health Manpower Management. 1997; 23(45):167-9.
     View PubMed
404. Ward JC, Gitlin JB, Garry DJ, Jatoi A, Luikart SD, Zelickson BD, Dahl MV, Skubitz KM. Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity. Br J Haematol. 1992 May; 81(1):27-32.
     View PubMed
405. Massouh M, Jatoi A, Gordon EM, Ratnoff OD. Heparin co-factor II activity in plasma during pregnancy and oral contraceptive use. J Lab Clin Med. 1989; 114(6):697-9.
     View PubMed